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Abstract 
Peripheral axonal excitability techniques represent a new exciting and accessible non-invasive 
research tool. Pathophysiological insights into many peripheral nerve disorders have been the 
main gain, with clinical application still in its infancy. A major limitation has been the small 
excitability changes seen compared to controls, with large variability in both disease and 
control groups. This raises questions of sensitivity. Furthermore, it is not known what the 
effects of remote central lesions are on peripheral excitability, with disparate plastic changes 
documented in literature.  
The purpose of this thesis was to correlate the changes of excitability in peripheral neuropathic 
disorders with their clinical signs and nerve conduction findings, and to examine for changes in 
peripheral nerves in a predominantly central nervous disease model. To do this, three 
disorders with well documented peripheral neuropathy were studied for their excitability 
properties for the first time. To look for a central effect on peripheral nerves, multiple sclerosis 
(MS) was studied, and results compared with studies of other lesional central nervous 
disorders. 
There were changes in excitability in two of our three peripheral neuropathy cohorts, 
indicative of ischaemic depolarisation. In end-stage liver disease, the changes were not 
reversible one year after liver transplantation. In HIV-positive subjects, changes were seen only 
in nucleoside drug-related neuropathy, and this appears to be the only neurophysiological test 
that can differentiate nucleoside from viral distal sensory polyneuropathy. In mitochondrial 
disease, motor studies showed no changes at rest or with experimental ischaemia.  
Sensitivity and subset comparisons indicate that in liver disease, some excitability changes 
correlated with peripheral clinical signs but not standard nerve conduction abnormalities. The 
reverse was true in mitochondrial disease. Roughly 20-25% of patients with end-stage liver 
neuropathy and nucleoside neuropathy were identified to fall outside control 95% confidence 
interval limits. 
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Upregulated slow K
+
 channels seen in peripheral motor axons of MS are possibly a response to 
enhanced persistent inward currents (PICs) at the motoneuron following suprasegmental input 
interruption. In contrast, peripheral sensory studies show increased fast K
+
 conductance 
through altered gating kinetics, possibly because of humoral factors acting locally to loosen the 
paranodal seal.  
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Part A Introduction 
Nerve conduction studies and axonal excitability 
Advantages and limitations of routine diagnostic studies 
The development of electronics advanced significantly during World War II, and allowed many 
improvements in the technique of measuring the electrical activity of individual neurons. 
Microelectrode recordings yielded data that gave rise to formulae to model the behaviour of 
axons. Other improvements also allowed the accurate recording of signals and their timing, 
facilitating standard nerve conduction studies (NCS), which have been the mainstay of studying 
nerve function in the clinical setting for many decades. These tests utilise the measurement of 
signals generated by summated or sensory nerve action potentials (SNAPs) in nerve, and 
compound action potentials (CMAPs) in muscle, and give us important information via their 
amplitude about the number of conducting axons and how fast they conduct (Kimura, 2001). 
In reality, a true estimation of the number of conducting axons is only had in motor axons via 
more accurate quantitative techniques such as motor unit number estimation (MUNE) and its 
different techniques (Bromberg, 2007). Conduction velocity is often taken from the onset of a 
SNAP or CMAP and therefore, tells us information regarding the fastest conducting fibres only.  
Nerve excitability and modern techniques of testing excitability 
The technique of determining the excitability of axons is actually not entirely new. They were 
used prior to, and were historically the first of 5 methods of electrodiagnosis in neurology 
(Purves-Stewart, 1952). Originally performed with short pulses of ‘Faradic’ current from an 
induction coil, or long pulses of ‘Galvanic’ current from a battery, the testing was crude but 
effective at determining the strength-duration relationship (see later) (Ritchie, 1944). This was 
facilitated with control of impulse delivery via a rheostat, and the measurement of impulses 
via a cathode ray oscilloscope. These earlier studies of nerve excitability and related 
‘accommodation’ were superseded by studies of conduction velocity when systems of 
measurement became more sophisticated. The accurate measurement of velocity allowed the 
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categorisation of neuropathies into demyelinating and axonal types (Fowler, 1995), and 
excitability studies started to decline. 
At their heart, excitability studies measure the ease with which an axon, or more commonly in 
this thesis, a group of axons, are likely to fire when the axon is conditioned, for example, 
depolarised. This has led to the usage of the term ‘threshold’ in the determination of 
excitability. The threshold indicates the current that is required to elicit a given response. In a 
single axon, this would be the current that is required to elicit an action potential (AP) in 50% 
of trials. In a group of axons, it could be defined as the current required to excite 50% of axons 
(Bostock et al., 1998, Burke et al., 2001, Bostock, 2004). This characterisation of threshold 
behaviour has given valuable insight into voltage-gated ion channels and ionic pump function, 
and through them into membrane potential. Many of the inferences have been derived from 
experiments on animal and human axons. It is proposed that this method is complementary to 
the study of diseased nerves with nerve conduction. While the immediate milieu of the 
peripheral axon may influence its excitability, the remote effects of for example, 
suprasegmental inputs in the central nervous system (CNS) on excitability of peripheral 
neurons, are poorly understood. 
Comparisons between the two techniques are considered. On the one hand, NCS techniques 
study the whole length of the nerve, whereas excitability studies only measure the properties 
of the axon at one point, in this case, directly beneath the stimulating electrode. Axons that fail 
to fire or those that are blocked will not contribute to the nerve conduction parameters, or 
excitability measures for that matter. However, nerve conduction has limited or no ability to 
demonstrate changes in membrane potential or specific ionic channel perturbations. This is 
possibly because neurons have evolved to maintain a resting potential where conduction 
velocity is maximal, resulting in significant redundancy in the homeostatic mechanisms studied 
here. The ability of the axon to fire is critical but once it does, large perturbations in excitability 
may be necessary to affect the conduction velocity of an impulse. NCS does however have the 
ability to look at conduction velocity very well, with its attendant inferences regarding nerve 
myelination. However, it should be remembered that aside from myelination, there are many 
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other determinants of conduction velocity which include membrane potential, ion channel 
behaviour, nerve morphometry (such as axonal diameter), and of course, temperature 
(Bostock, 2004). The ability of nerve excitability to identify demyelination at the site of testing 
can be limited. An impulse delivered often preferentially excites normal nodes not affected by 
demyelination, especially in non-uniform pathological acquired states of demyelination such as 
the inflammatory neuropathies.  
The time taken to acquire experimental data has been a major limitation of excitability testing 
in the past. Today, computer-controlled programs allow the rapid assessment of  various 
excitability parameters, and one of these developed by Professor Hugh Bostock, the QTrac 
system and its Trond protocol, is employed for the studies in this thesis (Bostock et al., 1998). 
The technique has the advantage of rapid computer-controlled testing, which combined with 
the non-invasive nature of the clinical protocols, has seen its re-emergence as an important 
tool in the study of the pathophysiology of neuropathy in the last two decades. 
Use of excitability testing in the clinical setting 
There are two major potential uses of this technique. The first and arguably most important of 
these has been a facilitation of our understanding of nerve pathophysiology. In a sense, this is 
complementary to other available techniques. Histopathology allows us to look at the 
microscopic changes in nerves, but neurophysiology has long afforded an elegant functional 
insight of what axons are supposed to do, which is to conduct impulses. Aside from this 
qualitative information, the second use which would apply to any new test is its ability to 
quantitate dysfunction. This would therefore be a study of sensitivity in the clinical setting. 
This of course, presupposes a gold standard of the presence of disease to measure this 
sensitivity by, but nevertheless, gives us information on the ability of the test to detect 
disease.  Reproducibility studies are required to validate any use in longitudinal study designs. 
Most of the studies that have been published in this area to date have been, not surprisingly, 
in peripheral neuropathic diseases. However, it is quite important to recognise that the 
function of peripheral somatic nerves, be they motor or sensory in nature, is influenced not 
only by the pathological processes in its direct environment, but also by the neural inputs it 
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receives from its synaptic connections. Therefore, it would be instructive to perform 
excitability studies in disorders of the CNS, not only to facilitate an understanding of how these 
neural circuits and networks function, but also to account for these changes when the test is 
used to study conditions where central and peripheral nervous system (PNS) disorder co-
exists. This can in future hopefully allow a correct interpretation of the relative contributions 
of each component. 
Determinants of axonal excitability 
Structure and function of the axon and myelinated cells 
Cells in the human body can differentiate into many different types. The cells of the nervous 
system are highly specialised, and share certain unique features. Broadly speaking, they are 
divided into the central (brain, brainstem and spinal cord) and PNS (cranial nerve, root, plexus, 
trunk and peripheral nerve). These two broad domains have many characteristics in common, 
as well as features specific to each.  
Historically, the neuron doctrine proposed by Cajal eventually dispelled the notion propagated 
by Galen that nerves are ducts whereby glands such as the brain would convey secreted fluids 
to the periphery (Kandel et al., 2013). Cajal’s microscopic analysis of neurons paved the way 
for the description of basic anatomical structure. All neuronal cells are composed of a cell body 
and neurites, or extensions. Neurites take the form of dendrites which receive input from 
receptors or synapses with other neurons, or a single tubular axon which is a projection of the 
neuron with a diameter from 0.2 to 20 µm. The axon can be quite lengthy, sometimes up to a 
metre long. The cell body is the metabolic centre of the neuron and is often angular or 
pyramidal in shape. Pyramidal neurons often have two sets of dendrites, a long slender set of 
apical dendrites or shorter stubbier basal dendrites.  
An axonal membrane or axolemma consists of a lipid bilayer surrounding a cell cytoplasm, with 
organelles and the cell nucleus within. The organelles are ribosomes, endoplasmic reticulum, 
and Golgi apparatus which are required for protein synthesis, much of which takes place in the 
cell body (Berthold et al., 2005). The major function of the cell soma is to synthesise 
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macromolecules, important for generic as well as specialised cell function. There are 
anterograde (from cell body to dendrite/axon) and retrograde (vice versa) trafficking systems 
that cater for the various energy and cell turnover functions of the neuron.  
Although most of the genetic material contained within cells is concentrated in the nuclei, a 
small amount is encoded in circular genetic material within the mitochondria. It is within these 
organelles that energy is generated from the metabolism of sugar and fats, and the process of 
oxidative phosphorylation that generates adenosine triphosphate (ATP) (see Chapter 4E). 
Most neuronal cells are highly polarised (Kandel et al., 2013). The purpose of propagation of 
impulses via these neurons is to convey information away from the CNS, such as to the motor 
unit, i.e. nerve and muscle in the peripheral motor system, and to the CNS, such as in the 
sensory system. Such impulses are usually formed in the axon hillock, the portion of the cell 
soma that adjoins the axon. Despite the neural networks being exceedingly complex, especially 
in the CNS, all neurons have homeostatic mechanisms which are at a basic level biochemical 
and organic, seeking to deliver a state of electrophysiological readiness. The homeostatic 
mechanisms of maintaining membrane potential and the ability to support action potential 
(AP) generation is derived from the various activities of its ion channels and pumps.  
In the CNS, neuronal cells also have a supporting network of other cells called glia or neuroglia. 
These do not take part in signalling. These cells are vital to the adequate function of the 
neuron, with the most apparent being that of those that lay down myelin. The others are 
astrocytes, which have important functions of potassium buffering for neurons when they fire 
repetitively, and microglia (phagocytes). In the PNS, the myelin-elaborating cells are called 
Schwann cells and in the CNS, they are called oligodendroglia. Peripherally, Schwann cells may 
invest the axon multiple times in concentric layers, which serve to not only interact with axons 
and preserve axonal integrity, but to concentrate electrical charge at the nodes of Ranvier, 
facilitating saltatory conduction (see later). The nodes of Ranvier are regular 1-2 µm long 
periodic interruptions in myelin occurring roughly 1-1.5 mm apart in large axons, and therefore 
can number up to 300 to 500 in a nerve of 0.5 m in length (Berthold et al., 2005). The spacing 
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between these nodes observes a complex curvilinear relationship with the diameter of the 
axon, and this geometrical relationship is such that conduction velocity is optimal (Salzer, 
1997). This may be the case for large diameter fibres, but single investiture is noted in small 
and unmyelinated axons or so-called C- fibres. A similar structure of axon wrapping is noted in 
the CNS for oligodendrocytes, but other supporting cells like astrocytes are also present. It is 
the oligodendrocytes that have been the subject of intense study in multiple sclerosis (MS), 
and believed to be the primary target of autoimmunity in MS.  
Schwann cells and oligodendrocytes differ both developmentally and biochemically. Genes in 
Schwann cells appear to turn on in the presence of axons (Heinen et al., 2013). However, the  
expression of genes in oligodendrocytes appears to depend on astrocytes (Bhat, 1995). Early 
during myelination in the periphery, the Schwann cell expresses myelin-associated 
glycoprotein (MAG). This protein is not greatly expressed in mature compact myelin. There are 
two isoforms with differing molecular weights, and MAG belongs to a superfamily that is 
related to immunoglobulins and includes cell surface proteins thought important in cell-cell 
recognition (e.g. major histocompatibility antigens, T-cell surface antigens, and neural cell 
adhesion molecules (Schnaar and Lopez, 2009).  
A major protein in peripheral myelin is P0. This acts to compact myelin as it spans the 
plasmalemma of the Schwann cell once and its extracellular glycosylated domains interact with 
each other. The central equivalent is proteolipid protein (PLP), another transmembrane 
protein important in the compaction and stabilization of myelin by binding to other proteolipid 
proteins. Both central and peripheral myelin contains myelin basic protein (MBP), a highly 
antigenic protein that interacts with lipids in myelin maintaining its correct structure. The 
injection of these proteins experimentally into animals has produced a cellular autoimmune 
response, called experimental allergic encephalomyelitis (EAE), which is characterised by focal 
nerve inflammation and demyelination. This experimental paradigm has been used by many 
investigators to study MS (Pender, 1988). However, despite many decades of research, it 
appears to have failed to adequately reproduce a suitable animal model of the human 
condition. 
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Near the end of the axon, there are branches that have specialised and fine endings called 
presynaptic terminals. It is via the synapses with other neurons that one neuron communicates 
with another, or to another type of cell. This anatomical basis is what determines two very 
fundamental principles of connectivity. Firstly, there is ‘dynamic connection’. This dictates that 
information flows in a consistent direction in each nerve cell, i.e., that the flow is from the 
receiving neurites of the cell, and then is relayed unidirectionally down the axon. The second 
principle is that of ‘connectional specificity’. This principle states that neural cells that 
communicate have no cyptoplasmic continuity even at the synapse, and that nerve cells do not 
connect randomly with one another, having precise points of communication for some 
postsynaptic cells and not others (Kandel et al., 2013). 
All neurons can be broadly divided into 3 functional categories: afferent, motor, and the 
largest group, interneuronal. Motor neurons carry information to muscles and glands, afferent 
neurons convey information for perception and regulation of motor functions, and 
interneurons serve to process information locally or connect areas of the nervous system with 
each other. 
Ion channels 
Ion channels are responsible for the resting membrane potential (RMP) and the generation of 
the AP. This section will look at how ion channels are selective, and give rise to these two 
phenomena.  
Ion channels can be divided into 3 different subclasses: voltage-gated, ligand-gated, or 
mechanically activated. These structures are inserted into the 6-8 um thick proteolipid 
membrane bilayer that is normally impermeable to ions. The impermeability of the lipid bilayer 
is partly because of the water molecules that they are attached to the ions (Hille, 1992, 
Siegelbaum and Koester, 2000). The membrane is hydrophobic. However, the ion channels can 
allow ions through selectively under the right conditions. There is usually a differential 
permeability that is altered when an AP is generated. For example, during the steady state 
RMP, potassium (K
+
) ions are 100 x more permeable than sodium (Na
+
) ions, but this reverses 
during the AP such that Na
+
 is more permeable transiently by 10-20 x.  
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Sodium channels (Na+). A sodium channel consists of a pore forming α-subunit and two 
accessory β-subunits which anchor the pore to the intra- and extracellular components. The β-
subunits are important for its kinetics and voltage dependence (Goldin, 2001). The 
predominant Na
+
 channel type at the nodes of Ranvier in peripheral axons is Nav1.6, 
responsible for both the persistent (Nap) and transient current (Caldwell et al., 2000, Goldin et 
al., 2000, Kaplan et al., 2001, Herzog et al., 2003) . Na
+
 channels are uniformly distributed in 
non-myelinated nerves, but in myelinated cells are clustered at the node. The density of 
channels is 1000/µm
2
 at the node and some 25/µm
2
 at the internode (Rosenbluth, 1976, 
Ritchie and Rogart, 1977, Chiu and Ritchie, 1981). Approximately 98% of nodal Na
+
 channels 
are of the classical transient type with fast kinetics of activation and inactivation, and the 
strongest currents occur at -20 mV (Scholz et al., 1993). A persistent Nap makes up only 1-2% 
of the current but appears to have a lower threshold of activation than the fast Na
+
 current by 
about 10-15 mV and is therefore, partially activated and active over a wider range of 
membrane potentials (Baker and Bostock, 1998, Baker and Bostock, 1999). It contributes 
disproportionately to subthreshold behaviour, along with the Barrett and Barrett conductance 
which is even more important (see later). The Nap current also appears sensitive to acid-base 
alterations with a lower pH reducing permeability (Baker and Bostock, 1999). The persistent 
currents may be important in modulating neuronal excitability and amplification of 
subthreshold depolarisation inputs, which may be a factor for repetitive neuronal firing 
(Taddese and Bean, 2002, Tokuno et al., 2003). Sensory axons have been shown to have longer 
strength-duration time constants, a measure of Nap current (see later), and this may be the 
reason they are more likely to manifest ectopic impulse activity than motor axons. Both the 
transient and persistent currents are blocked by tetrodotoxin and saxitoxin, are found in rat 
dorsal root ganglia, and appear to be present in human axons (Bostock and Rothwell, 1997). 
Therefore in summary, in peripheral nerve axons, Nav1.6 is the important isoform, capable of 
generating both transient and persistent currents, the former critical for AP generation, the 
latter of importance for setting membrane potential.  
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Potassium channels (K+). Eight different potassium channels have been identified in 
mammalian axons (Vogel and Schwarz, 1995), at least five of which are present on human 
axons (Reid et al., 1999). Four families have been identified – shaker, shal, shab and shaw. 
There are 4 subunits (α or β), each with 6 membrane spanning domains. In broad categories 
according to their kinetics, there are two fast components (IKf1 and IKf2), and one slow (IKs). 
Their kinetics and pharmacological blockers are summarised below (Table 1.1). Each 
component depends on the subtypes of Kv channel which are distinguished by their membrane 
potential dependence and inactivation rate. These Kv channels can be divided into fast (F), 
intermediate (I) and slow (S) (Jonas et al., 1989, Safronov et al., 1993). 
Table 1.1. Potassium channel properties 
Type Distribution 
Active voltage 
range  
Pharmacologic
al blocker Role 
Fast (IKf2) 
Paranode 
12/µm
2
;
 
Internode 2/µm
2
 
-40 to 
+40/60mV 
4AP 
Limit the charge to 
the node by limiting 
the depolarising 
afterpotential 
Intermediate (IKf1) * 
Paranode 30/µm
2
 
Internode; 
-70 to-40mV 4AP, α-DTX 
As for fast; 
Participates in 
conduction block if 
axon demyelinated 
Slow (IKfs) 
Node 110/µm
2
; 
 
Internode 4/µm
2
 
-70mV** TEA/ Ba
2+
  
Limit depolarisation 
and repetitive firing; 
Contributes to the 
resting membrane 
potential** 
*has 2 modes of gating – ‘noisy’ and ‘flickery’; flickery blocked by α-DTX (alpha-dendrotoxin); 4AP (4-
aminopyridine); Ba
2+ 
barium; **about 30% of these are active at resting membrane potential.  
In human axons in vivo, there is evidence for only two potassium currents, ‘fast’ and ‘slow’, 
possibly corresponding to combinations of IKi and IKs, and probably because the threshold for 
IKf1 and  IKf2 extends into a suprathreshold region so that they cannot be identified reliably with 
available techniques. Fast K
+
 channels are very few at the node and do not contribute greatly 
to the AP (Schwarz et al., 1995). Repolarisation after the AP is mainly from inactivating Na
+
 
gates in mature myelinated fibres (see later) and fast IKf is not responsible. There are fast K
+
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channels concentrated in a tight band in the paranodal region, which contribute to the 
resistance of the internodal membrane, limiting the depolarising afterpotential (DAP) which is 
primarily responsible for superexcitability. Slow K
+
 channels are more plentiful at the node. 
They are important to the RMP and the accommodative response to long lasting depolarising 
stimuli. Partial activation gives rise to the late subexcitable period and the subexcitability that 
follows impulse trains. Once thought to be too slow to influence the AP, slow K
+ 
channels can 
limit the duration of the AP (Burke et al., 2009). Approximately 35% of the slow K
+ 
channels are 
open at the RMP and it is likely that the large change in the membrane potential during the AP 
drives this current, and contributes to limit excitability (Röper and Schwarz, 1989). In contrast, 
fast K
+ 
channels cannot participate in adult neurons as they are sequestered under myelin. 
There are other K
+ 
channels that are sensitive to Ca
2+
, Na
+ 
and ATP. Ca
2+ 
-sensitive K
+ 
channels 
activate in response to increases in intracellular calcium (as occurs with hypoxia and 
hypoglycaemia) and membrane depolarisation. They are less voltage sensitive, and are 
responsible for membrane repolarisation in some cells, and even limit the after-
hyperpolarisations that are generated following an AP. Na
+
-activated K
+ 
 channels are in close 
proximity to the Na
+
 channels, and can be active after single or multiple impulse trains, leading 
to a depression in excitability. Na
+
-K
+ 
ATPase sensitive K
+ 
channels are voltage-insensitive and 
remain open over a wide range of voltages. They become activated in hypoxia and low-energy 
states, and this causes hyperpolarisation and protects the axon from depolarisation that is 
caused by ischaemia. Kfl or flicker channel permits a voltage-independent leak current mainly 
on thin myelinated axons. 
In demyelination, K
+ 
currents can be recorded from the paranodal regions. This may be due to 
the exposure of both fast and intermediate K
+
 channels, which can mediate conduction block. 
Application of 4AP restores conduction in some but causes repetitive firing in others (Baker 
and Bostock, 1992). 4AP has been studied in MS (see later) and is now available for clinical use 
in humans as the agent fampridine.  
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Inward rectification (Ih). This current was first recorded by Lorento de Nó (Lorente de Nó, 
1947) in frog nerves as a slow relaxation of the potential change induced by hyperpolarising 
current. There are 2 types: 
Classical inward rectifier (Kir). This, passes a large inward K
+ 
current below the equilibrium 
potential for K
+
, and has only a minimal outward current. These have a role in maintaining RMP 
and controlling excitability, and are blocked by Ba
2+
 and Cs
+
. 
Hyperpolarisation activated current (Ih): This was first seen in cat motoneurons (Araki et 
al., 1961), and is sensitive to Cs
+
. Recordings of threshold electrotonus have shown that it 
occurs in humans (Bostock and Baker, 1988) and that it is more pronounced in sensory than 
motor axons (Bostock et al., 1994). The hyperpolarisation-activated cyclic nucleotide-gated 
(HCN) channel allows the passage of both Na
+ 
and K
+ 
ions. They are most active at a range of -
50 mV to -100 mV with slow steady state activation, and reverse at -50 to -20 mV. There are 4 
subunits, HCN 1-4, and homeomeric and heteromeric combinations decide functional 
variations of the channels (Moosmang et al., 2001).These subunits have cyclic nucleotide-
binding domains to cause their activation, and HCN1 and 2 have been the most studied in 
mammalian neurons (Wahl-Schott and Biel, 2009). Studies show this channel is responsible for 
the RMP as well as generating rhythmic oscillations (Pape, 1996). The activation state appears 
to be regulated by basal activity of adenylate cyclase and intracellular concentrations of cyclic 
AMP(c-AMP) (Howells et al., 2012). It is primarily internodal in location, and appears to limit 
the excessive hyperpolarisation mediated via Na
+
-K
+
 pump activation that can follow trains of 
impulses or a period of ischaemia (Bostock and Grafe, 1985) in both myelinated and 
unmyelinated axons (Baker et al., 1987, Grafe et al., 1997). Ih helps prevent conduction failure 
in damaged nerves  and also in natural regions of reduced safety factor such as branch points 
(Parnas, 1972) and nerve terminals (Krnjevic and Miledi, 1959). Ih seems to be more active in 
sensory than motor axons by a factor of 2 (Bostock et al., 1994, Lin et al., 2002, Kiernan et al., 
2004) and this could result in them being more protected from conduction block. 
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What contributes to ionic permeability in membranes?  Ions such as Na+ and K+ have a 
natural attraction to the oxygen species in the polar water molecule, and they firstly need to 
shed their ‘waters of hydration’ to be able to move down the channel. The inner surface of a 
channel pore contains polar amino acid residues which are negatively charged and attract 
cations like Na
+
 and K
+
. This electrostatic interaction has to exceed the energy required to shed 
the attraction of water molecules. The kinetics of ion flow through the channel is dependent 
on the size of the channel and the voltage-dependence of its gating mechanism. The ease with 
which channels allow its specific ions through can be quantified as conductance (siemens as 
unit) which is the reciprocal of resistance (ohms as unit). Therefore, channels can be seen as 
resistors with flow changing according to the driving force for that ion down its gradient. 
Where this flow of ions is directly proportional, it follows a linear relationship with the driving 
force, but when it is non-linear, the channel is described as a rectifier.  The opening and 
closure of ionic pores is brought about by conformational changes of the channel. This thesis 
studies primarily the effects of voltage-gated ion channels.  
Other ion channels and pumps, the resting membrane potential, the action potential, and 
conduction velocity 
The process of impulse conduction at its unitary level is a product of a complex system of ionic 
pores, both at the node and internode in a state of rest or activation. In neurons as with other 
cells, there is a difference in concentration of ions across the cell membrane. Na
+
 and Cl
-
 are 
concentrated outside the cell, and K
+
 and organic anions such as amino acids which are 
negatively charged are concentrated inside the cell. The Na
+
 concentration is roughly 10 x 
more concentrated outside, and K
+
 ions some 50 x more concentrated inside the cell. In glia, 
the cells are mainly permeable to K
+
 only. However, in neurons, the main players are Na
+
, K
+
 
and Cl
-
 ions. The resultant ionic concentration difference or gradient, especially for the 
aforesaid three ions, is what generates an electrical RMP for that ion, which according to the 
Nernst equation is equivalent to the opposing electrical force or gradient for this natural flow 
of ions. The overall effect of the various ionic gradients and their opposing forces is given by 
the RMP.  
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The main generator of the RMP is the result of the relative permeability of the membrane to K
+
 
ions and the impermeability to Na
+
 ions. As K
+
 moves out of the cell, the un-neutralised 
negative charge left behind generates a RMP that is negative on the inside. In mammalian 
axons, this is in the order of -60 to -70mV, internal in relation to external (Hammond, 2001). 
When this RMP moves closer to zero, it is said to be in a state of relative depolarisation, and 
when further away from zero than its usual state, it is in a state of relative hyperpolarisation. 
More recent work utilising modelling studies has suggested a revision of the RMP of motor and 
sensory axons to be closer to -84 and -81mV respectively (Howells et al., 2012). This applies to 
both the nodal and internodal components. Physiological (as opposed to chronic pathological) 
states of depolarisation and hyperpolarisation increase and decrease the ability of the cell to 
generate a signal, and are therefore, relatively excitatory or inhibitory respectively. 
Na+-K+ ATPase pump. The maintenance of a membrane potential which balances the ionic 
concentration differences requires active pumps and consumes energy. Without these, ionic 
diffusion would cause a dissipation of current and the membrane potential would not be 
maintained and run down. Therefore, there are Na
+
- K
+
 pumps which are integral membrane 
proteins, consisting of α2β2 subunits, that work to exchange 3 Na
+
  ions out for 2 K
+
 ions in, to 
balance the passive flux of these ions in the opposite direction. This pump channel is blocked 
by ouabain, and is highly energy-dependent, utilising ATP. A similar effect of blocking the 
pump using experimental ischaemia, and to produce an ionic imbalance in the post-ischaemic 
period when the pump overdrives to cause hyperpolarisation, is studied in Chapter 4E. About 
7-10% of RMP maintenance is ascribed to the pump (Thomas, 1972, Bostock et al., 1998), with 
the rest due to activity of channels that are open at or near rest, be they voltage-dependent or 
otherwise. The majority of these lie in the internode, with the major contributors being slow 
and fast K
+ 
 channels, persistent Na
+ 
 channels, and the Na
+
-K
+ 
 pump. 
The Na+-Ca2+ exchanger. This ionic pump normally works to extrude Ca2+ outwards in 
exchange for Na
+ 
inwards, and is driven by the electrochemical gradient of Na
+
 concentration. 
There is probably an exchange ratio of 2-3 Na
+ 
ions for one Ca
2+ 
ion. This maintains 
homeostasis but there may be a reversal of the exchanger, not only at the peak of the AP, but 
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when the Na
+
 concentration is reversed. Such a situation may arise when the intracellular Na
+
 
concentration rises as the result of pump paralysis/ischaemia or other pathological states. The 
end result is increased intracellular Ca
2+
 which is deleterious to the biochemical function and 
integrity of axons. Blockade of this channel or the Na
+ 
channel may be neuroprotective (Kapoor 
et al., 2003, Bechtold et al., 2004, Bechtold and Smith, 2005, Bechtold et al., 2005). There may 
also be a use in targeting this channel in disorders characterised by central and peripheral 
inflammation, with potential neuroprotective effects (Waxman, 2005). 
The action potential . The conduction of an action potential (AP) or propagation of an AP is 
the primary function of axons. The behaviour of its ionic channels is what drives this process, 
giving rise to fluid membrane potential changes that are well documented with 
electrophysiological cellular studies. At rest, the RMP is closer to the Ek, the Nernst equilibrium 
for K
+
. In human axons in vivo, this is more in the order of -80- to -85 mV, a greater potential 
difference than previously thought (Howells et al., 2012). An initial driving force, be it physical 
or chemical, is presented either via a specialised receptor or directly to the surface of the 
neuron/axon. This results in a transient depolarisation that shifts the membrane potential 
towards zero. Only a small excursion of the membrane potential is required before the process 
becomes regenerative in a process brought about by increasingly large proportional opening of 
Na
+
 channels. This is the point of ‘threshold’, and for that cell may be only 10 mV away from 
the RMP. The regenerative nature is because the influx of Na
+
 ions brings about greater 
depolarisation which in turn, allows a greater influx of Na
+
. After this large influx of Na
+ 
 ions 
through voltage-sensitive Na
+
 channels, there is such a sizeable flow of current such that the 
membrane potential may actually be as much as +55 mV inside relative to outside. At this 
point, the membrane potential approaches but does not reach the Nernst equilibrium for Na
+
, 
ENa. The process of AP generation that occurs after this threshold is reached is an ‘”all or none” 
response. It ends with the closure of the majority of Na
+
 channels by an inactivation gate which 
is sited on the internal portion of the channel. Together with current leak, it is this closure 
which is primarily responsible for repolarisation of the axon (Chiu et al., 1979, Brismar, 1980, 
Schwarz et al., 1995).  
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Conduction and conduction velocity are determined by several factors which include the 
axon’s morphometric properties. These properties have passive membrane properties which 
do not change with signalling. One of these is the diameter of the axon: the larger the axon 
diameter, the faster the impulse, and the more excitable the axon. This increase in excitability 
is because of the resistive properties of the charge flow down a hollow axon tube being offset 
by a larger concentration of ions per unit length. Myelination functionally increases the axonal 
membrane thickness by 100 x. The increase in the fibre diameter by this insulating material 
causes a much greater decrease in membrane conductance than would be had by simply 
increasing the axonal diameter by that amount. Studies have also determined an optimal 
myelin thickness for a fixed size of axon (Smith and Koles, 1970). However, there is a natural 
dissipation of current as it flows down a myelinated axon. To counteract this, the myelin 
sheath is interrupted by the nodes of Ranvier, each some 2 µm in length, where there is a high 
density of Na
+ 
ions, which can generate an intense depolarising inward current in response to 
the passive spread of depolarising current from the axon upstream. This is called the nodal 
driving current. Because ionic channel flow is restricted to the nodes, there is less energy 
expended by the Na
+
-K
+ 
pump in restoring the concentration gradients for those two ions. As 
mentioned previously, other important factors for conduction velocity are temperature (lower 
temperatures slow speed of propagation via effects on the Na
+
 inactivation gate) and RMP 
(both depolarisation and hyperpolarisation can slow conduction).   
The purpose of saltatory conduction is to propagate impulses down the axon in an efficient 
manner. The generation of an impulse de novo is a result of the various integrative 
components of that neuron at its trigger zone, with the excitatory and inhibitory inputs 
processed and leading to AP generation as an all or none response. Once this has been 
achieved, a basic property of this impulse is its ability to sustain itself as well as propagate at 
speeds that allow that information to reach its destination in adequate time, or with sufficient 
resolution from other impulses in its neural network to mediate its effect. The AP itself is very 
stereotyped and varies little even between afferent and efferent networks. The specific effects 
of firing frequency, lateral inhibition, facilitation and parallel processing (i.e., the deployment 
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of several groups of neurons or pathways of neurons to convey the same information) are 
complex and beyond the scope of this literature review, but in essence, there is a dependence 
on impulse propagation to fulfil its aims at a unitary level.  
Eventually, an impulse will arrive at another neuron whereby it will communicate via a 
synapse. This synapse may be to the cell body, or more likely on the dendrite of that 
communicating cell. The axons of an α- motor neuron or ‘lower motor neuron’ synapse with 
muscle fibres via the neuromuscular junction. This promotes the release of the 
neurotransmitter acetylcholine from vesicles at the presynaptic portion. This neurotransmitter 
floods the cleft and postsynaptic receptors, and generates miniature endplate potentials 
(MEPPs). The MEPPs then summate to reach a threshold that in turn causes depolarisation of 
muscle membrane and finally excitation-contraction coupling (Kandel et al., 2013). 
Measures of axonal excitability 
Threshold 
There are two main definitions of threshold in axons. For a single axon, it is defined as the 
strength of an impulse that is required to initiate an AP in 50% of trials. Alternatively, for a 
group of axons as occurs in a nerve bundle, threshold can be defined as the stimulus strength 
required to initiate APs in a fixed proportion, say 50%, of the axons. Clearly, the second will 
activate the axons with the lowest thresholds, and this may not necessarily reflect the 
properties of the whole nerve bundle.  
There is a ‘grey area’ of about 6% of threshold where it is probabilistic that a single axon will 
be excited. In this area, it will require many trials to derive the threshold. To measure 
threshold change, one can measure in a group of axons, the change in response from a fixed 
stimulus strength, or measure the change in stimulus required to elicit a fixed response (see 
the stimulus response relationship illustrated in Figure 1.1).The latter is more efficient to 
derive threshold when measuring from the steepest part of the stimulus response curve, 
where the minimum number of stimuli are required. The process of ‘tracking’ is negative input, 
adjusting the stimulus strength up or down based on the whether the response is below or 
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above the tracked target respectively. For the purpose of this thesis and the experiments 
contained within, the threshold refers to the current required to produce a CMAP that is ~40% 
of maximum size, and this will be the target amplitude that was tracked. 
This measure of threshold is still not so useful when measuring from individual to individual 
because of the factors that contribute to current access to the nerve in the clinical setting, 
such as for example, the thickness and impedance of skin and overlying connective tissue 
above the nerve. It is the relative changes in threshold brought about in deriving strength-
duration relationships, and with prior conditioning currents of supra- and sub-threshold 
intensity, that give more useful information about excitability properties of nerve.  
Figure 1.1. Stimulus response relationships – fixed stimulus and fixed response 
 
C, E and D are different responses to a fixed stimulus with C and D at +10% depolarising  and -10% 
hyperpolarising conditioning current repectively; A, E and B are different stimulus levels to elicit a fixed 
response with A and B after +10% and -10% conditioning current respectively. Reproduced from Bostock 
et al (Bostock et al., 1998). 
Strength-duration properties 
From a stimulus-response (SR) curve, a target response can be set using the constant response 
and varying stimulus technique described above. For a given target response, duration of a 
stimulus increases as strength of the stimulus decreases, and vice versa. Rheobase is defined 
as the amount of current of infinitely long duration needed to excite or achieve threshold, and 
chronaxie is the duration of the impulse that corresponds to twice the rheobase. Chronaxie 
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also corresponds to strength-duration time constant (SDTC, τSD), a measure of the rate at 
which the threshold current for the target potential decreases as the stimulus duration is 
increased. It is a property that can be defined by Weiss’ law:  
Q=I.t  
where Q is the charge, I is the current and t is the stimulus duration.  
Note Q  = I.Rh (t +τSD) 
where Rh is rheobase.  
Using a ratio between two different stimulus durations of 0.2 and 1 ms, Weiss’ formula can 
provide a  
τSD = 0.2 (I0.2 – I1.0) / [I1.0 – (0.2 x I0.2)] 
The τSD has been shown to be directly related to the Nap current, but is also influenced by 
passive membrane properties. This parameter can be defined at the very least by plotting two 
points in a replotted straight line relationship between stimulus charge, Q and stimulus 
duration, t (see Figure 1.2 below). In this graph (B), rheobase is the slope of the curve, and τSD 
is the x-intercept. Both of these are nodal properties, and in humans, τSD has been estimated 
to be roughly 0.46 ms in motor and 0.67 ms in sensory axons (Mogyoros et al., 1996). It should 
be noted that this property is not only dependent on the site of stimulation along a nerve such 
as has been shown in the median nerve (Mogyoros et al., 1999) but also the position of the 
stimulating electrode on the wrist (Lin and Bostock, unpublished observations). 
When an axon discharges, its excitability fluctuates for approximately 100 ms as it passes 
through phases of absolute refractoriness (whereby the axon is impossible to excite), relative 
refractoriness, superexcitability (whereby the axon is easier to excite) and finally 
subexcitability, before returning to a steady state.  This process can be studied in the ‘recovery 
cycle’, in which a test stimulus is delivered after a conditioning supramaximal discharge, and 
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the conditioning-test interval is altered (Figure 1.3). The absolute and relative refractory 
periods 
Figure 1.2. Current strength - stimulus duration and charge-duration plots 
 
Note that the SDTC revealed in the x-intercepts extrapolated from the linear plots (B) is related to 
chronaxie in (A). Reproduced from Mogyoros et al (Mogyoros et al., 1996)  
have been estimated to be < 3 ms in humans (Gilliatt and Willison, 1963, Hopf et al., 1976). 
Following this, the superexcitable period is from approximately 3-18 ms, and the subexcitable 
period follows from 18-200 ms.  
The refractory period is determined by the inactivating Na
+
 channel gate on the internal aspect 
of fast Na
+
 ion channel. The absolute refractory period corresponds to the closure of these 
inactivating gates, and the relative refractory period (RRP) is the recovery from inactivation 
which corresponds to the opening of these inactivating gates. It is sensitive to membrane 
potential as depolarisation increases the refractory period and hyperpolarisation decreases the 
refractory period. The kinetics of the inactivating gate is also sensitive to temperature, with 
lower temperatures prolonging the refractory period.  
The superexcitable period is produced by the DAP. This DAP is the result of capacitative 
charging of the internode, and it subsequently discharges through or under the myelin sheath, 
and this is known as the Barrett and Barrett current (Barrett and Barrett, 1982). This current 
has a time constant between 20 and 100 ms.  The restriction in charge to the node is aided by 
the large myelin capacitance and both end up being depolarised for some tens of milliseconds. 
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The superexcitable period is also sensitive to membrane potential. Membrane depolarisation 
reduces the net imbalance of ionic flow, and the greater degree of open K
+
 channels in the 
depolarised state also tends to shortcircuit the afterpotential. 
The subexcitable period is due to the decaying hyperpolarisation that occurs as slow K
+
 
channels activated by the conditioning stimulus gradually close. It does not appear until 
approximately 15 or so milliseconds after the conditioning impulse because the increased 
threshold due to hyperpolarisation is superimposed on the preceding superexcitability.  This 
phase is sensitive not only to the membrane potential but also the electrochemical gradient of 
K
+
. Therefore, it is affected by the extracellular concentration of K
+
. The slow K
+
 channel effect 
is also seen in the short lasting P1 phase of post-tetanic hyperpolarisation. This corresponds to 
the phase of increased threshold described as H1 by Bergmans (Bergmans, 1970). It can be 
abolished by tetraethylammonium (TEA). By contrast, the effect of long impulse trains (H2) is 
brought about by Na
+
-K
+
 pump. The extrusion of 3 Na
+
 to 2 K
+
 ions by this pump increases 
threshold by hyperpolarising the axon, which can have a lengthy effect. H2 is reduced by 
cooling or ischaemia, and can be abolished by ouabain as described previously.  
Figure 1.3. Recovery cycle 
 
Phases of absolute and relative refractoriness that add to become the RRP, followed by the super- and 
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With the phases of excitability seen in the recovery cycle above, one cannot strictly state that 
processes predominant in each phase do not overlap. In fact, they do significantly. For 
example, the major process affecting AP duration and the relative refractory period may be 
inactivation of Na
+
 channels, but slow K
+
 channels are also important (see earlier). There is a 
sequence of overlapping processes such that strictly speaking, the RRP is not solely a measure 
of Na
+
 channel inactivation. 
Conditioning by subthreshold currents –latent addition, threshold electrotonus, and the 
current-threshold relationship  
Latent addition.  This technique uses very short impulses to determine the time constant of 
the nodal membrane. This is determined by the passive membrane properties and channels 
that are active at rest, particularly Na
+
 channels operating in persistent mode. The test 
stimulus is delivered after a very short depolarising or hyperpolarising pulse (both 60 µs long 
and up to 90% of the control threshold current) in one reported technique (Bostock and 
Rothwell, 1997). It was concluded that latent addition revealed characteristics of non-classical 
voltage-dependent ionic currents that were active close to the RMP, and these are different in 
motor and sensory axons. 
Depolarising threshold electrotonus (TEd). This is the only physiological measure of 
internodal conductances in human subjects possible in vivo. Threshold changes are recorded 
with a test stimulus presented at various latencies after the beginning of a 100 ms-long 
conditioning current that is 40% of the control threshold current (Fig. 1.4). The first phase of 
this depolarising threshold electrotonus follows a passive time constant where there is a 
sudden reduction in threshold. This fast ‘F’ phase is then followed by a short ‘S1’ phase where 
the current moves to and depolarises the internodal membrane. The peak of this threshold 
change is reached at roughly 20 ms, and this is followed by a move to higher threshold levels in 
an accommodative response. This is caused by activation of hyperpolarising conductances in a 
reaction that is meant to counteract the reduction in threshold, and is mediated by slow K
+
 
current which is located on both the node and internode (Baker et al., 1987, Bostock and 
Baker, 1988). When the depolarising conditioning current is terminated, there is a rapid return 
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of the threshold to control levels, and an apparent ‘overshoot’ which represents the persistent 
increase in slow K
+
 conductance and its slow kinetics of recovery.  
Hyperpolarising threshold electrotonus (TEh). In this experiment, the hyperpolarisation of 
axons at the wrist was produced by reversing the direction of current flow so that the 
electrode at the wrist became the anode and the remote electrode, off the nerve, became the 
cathode. The amount of conditioning current applied in this way was 40% of the threshold  
current. The test stimulus initially records a fast ‘F’ phase, again reflecting the passive 
properties of the axon. However, unlike depolarising threshold electrotonus, there is a 
continuing change of threshold increase as more K
+ 
channels become closed, which increases 
the initial ‘S1’ effect in that direction. After approximately 150 ms, there is a reversal as 
accommodation from inward rectification (Ih) becomes apparent. In fact, the effect of inward 
rectification is present well before 100 ms but is not obvious until later. On termination of the 
DC current polarisation, there is a sudden increase in excitability which surpasses the control 
level which is again the fast phase of TE due to nodal properties, and the ‘undershoot’ that 
follows represents persistence of the inward rectifier in its slow return to the baseline. 
Figure 1.4. Threshold electrotonus 
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hyperpolarising conditioning current) that seek to limit threshold change. Conditioning currents are at 
±20% and ±40% of unconditioned threshold. 
Current-threshold relationship. This relationship is analogous to threshold electrotonus, 
but instead utilises a fixed 200 ms duration conditioning current which varies in steps of 10% 
from +50% (depolarising) to -100% (hyperpolarising) of threshold. Outward rectification or a 
slow K
+
 effect steepens the curve at the top right hand corner of the graph and inward 
rectification (Ih) steepens at the lower left hand corner (Fig. 1.5) 
Figure 1.5. The current-threshold relationship 
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Note the effect of outward rectification (slow K
+
) and inward rectification (Ih) to reduce the threshold 
change in depolarising and hyperpolarising conditioning currents. 
Differences according to modality (sensory vs motor) and region (site, proximal vs distal) 
The stimulus-response curve is steeper for motor than for sensory axons, which likely reflects a 
more restricted range of axon diameters (Kiernan et al., 2001). The τSD is also  longer in sensory 
axons, and first believed to be due to a greater activity of Nap currents, perhaps accounting for 
their higher ectopic activity (Mogyoros et al., 1996). However, as has been demonstrated by 
Howells et al., it is now thought that this difference in Nap is more likely because of a relatively 
depolarised state of the sensory axon (as discussed prior) (Howells et al., 2012).  
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In the recovery cycle, both superexcitability and subexcitability appear larger in motor axons. 
The reasons for this are not clear, and it has been proposed that the current path connecting 
the node and internode has higher resistance in sensory axons (Kiernan et al., 2001). This could 
also underlie the existence of a lower rheobase and longer τSD in sensory axons, and its lesser 
susceptibility to conduction block.  
Sensory axons have greater accommodation to hyperpolarising stimuli, secondary to greater 
activity of Ih currents (Bostock et al., 1994, Lin et al., 2002). Recent modelling studies suggest 
that this is actually due to a greater proportion of ‘fast’ HCN channel isoforms  that are open at 
rest in the sensory than motor axons (Howells et al., 2012)..  
Different nerves appear to have different excitability properties. Median sensory axons have 
larger accommodation than the sural sensory axons which is perhaps because of greater 
activity of nodal and internodal slow K
+
 currents, as well as internodal Ih. Sural afferents 
undergo less ischaemic depolarisation and post-ischaemic hyperpolarisation (Lin et al., 2000). 
For motor nerves, higher intensities are required for stimulation of the peroneal than median 
nerves. Median motor axons appear to have higher accommodation to depolarising 
conditioning current and greater subexcitability than peroneal motor axons when stimulated 
at the ankle, which may be explained by higher slow K
+
 currents (Kuwabara et al., 2000, 
Kuwabara et al., 2001).  
Proximal-distal gradients have been suggested in the recovery cycle of experiments using 
peroneal nerve stimulation at the ankle and knee (Kuwabara et al., 2000, Krishnan et al., 
2004). The combined evidence points to an increase in suberexcitability in proximal rather 
than distal portions of nerves innervating the same muscle (i.e. extensor digitorum brevis), but 
this was less clear for superexcitability.  The findings suggest that there is a greater activity of 
slow K
+
 in proximal motor fibres, like that noted in sensory fibres before (Lin et al., 2000), and 
this was given as evidence of a length-dependent effect, which could possibly explain the 
greater ectopic activity from the proximal motor axons (Kuwabara et al., 2001, Krishnan et al., 
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2004). However, neither experiment tested a nerve fascicle, at proximal and distal sites, that 
innervates the same muscle in the same experiment. 
All the above may partly explain the different susceptibilities of motor and sensory axons. 
Sensory axons appear more sensitive to depolarising stressors with the greater Nap and Ih. This 
confers greater excitability and more ectopic activity. On the other hand, motor axons are 
more susceptible to hyperpolarising stress and therefore, that may account for their 
propensity for conduction block, especially in demyelinating diseases. These accord with the 
clinical picture in those demyelinating disorders where motor fibres appear more affected. 
Proximal-distal gradients of excitability differences may also be another explanation for the 
length-dependent clinical appearance of many peripheral neuropathies, and  axoplasmic 
transport factors may be the underlying reason for both.  
Changes with age, sex and temperature 
In the early stages of maturation and before adolescence, motor studies reveal that with 
increasing age, there are reductions in threshold, rheobase, changes to depolarising and 
hyperpolarising threshold electrotonus, and the resting current-threshold slope. However, 
there is increased refractoriness and subexcitability. These differences suggest a decrease in 
passive membrane conductances and K
+
 conductances that accompany myelination (Farrar et 
al., 2013).  
The effect of age has mostly been studied in motor nerves to date (see Table 1.2). There is a 
consensus that there is a decrease in superexcitability and an increase in Ih (Jankelowitz et al., 
2007, Bae et al., 2008, McHugh et al., 2011). The reduction in superexcitability may be related 
to an effect of age on muscle and its recovery cycle rather than on nerve, as there were no 
changes in RMP in the studies. Myelin thinning as might occur with age would not be expected 
to have much effect on the passive membrane properties to influence this parameter (Tamura 
et al., 2006), and therefore, the increase in τSD found by Bae et al. was felt to be due to 
increased nodal persistent Na
+
 current , resulting in slightly depolarised axons in elderly 
subjects (Bae et al., 2008). 
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In standard nerve conduction, the amplitude of the sensory action potential is well known to 
be greater in females. This has been ascribed to inherent differences in tissue characteristics 
by gender rather than a greater number of conducting axons. In studies of motor axons in 
females, there were noted to be lower thresholds (Yerdelen et al., 2006, Bae et al., 2008, 
McHugh et al., 2011) (see Table 1.2). This again is likely to be accounted for by improved 
current access factors, and a similar finding was seen in sensory axons (Kiernan et al., 2001). 
Table 1.2. Effect of age (after maturation) and gender on motor excitability 
 Rheobase τSD SR slope TEd Ih RC 
Age  
Jankelowitz et al. (2007) ↑  ↓  ↑ ↓super 
Bae et al. (2008)  ↑  ↓ ↑ ↓super 
McHugh et al. (2011)   ↓  ↑ ↓super 
Gender (females c.f.  males)  
Yerdelen et al. (2006) ↓ ↑*     
Bae et al. (2008) – under 50 yrs ↓   Early ↑  ↑super; ↑sub 
McHugh et al. (2011) ↓   ↑accom  ↑super; ↑sub 
* increase in SDTC in males only in older subjects; accom = accommodation. 
In addition, McHugh et al. and Bae et al. agreed that there was increased super- and 
subexcitability in females (Bae et al., 2008, McHugh et al., 2011).  
Cooling has the effect of increasing the RRP, slowing the accommodation to depolarising 
currents, and increasing the τSD. These changes appear to be mostly instantaneous. In 
threshold electrotonus however, whereas accommodation to depolarising conditioning 
currents is also immediate, the threshold decrease to hyperpolarising conditioning current has 
a delayed effect because of the effect of warming to increase the activity of the Na
+
-K
+
 pump. 
This delayed effect causes a minor resultant transient hyperpolarisation (Kiernan et al., 2001). 
A hyperpolarisation was also felt to be important in modelled hyperthermic experiments, 
where slow K
+
 currents may be important in reducing axonal excitability (Howells et al., 2013).  
Chapter 1- Literature review 
 
39 
Manoeuvres that alter the resting membrane potential 
Ischaemia  
There have been several reports on the effect of experimental ischaemia on excitability that 
far predate the techniques that are described in this thesis. The most frequent methodology 
used is that of inflation of a sphygmomanometer cuff at the upper arm with excitability studies 
conducted prior, during and after release of inflation. This method has been studied with the 
Trond protocol (Kiernan and Bostock, 2000). Ischaemia causes paralysis of the Na
+
-K
+
 pump 
which in turn causes Na
+
 ions to accumulate inside the cell, and K
+
 ions to accumulate outside 
the cell. During the ischaemic period of the experiment, the axon passes through a phase of 
increased excitability with membrane depolarisation, and then decreased excitability with 
membrane hyperpolarisation. Increased excitability accompanying depolarisation is evidenced 
by a shift to the left of the SR curve (see Figure 1.1). There is a steepening of current-threshold 
relationship as slow K
+
 is activated. Threshold electrotonus becomes ‘fanned in’ as threshold 
changes to depolarising and hyperpolarising conditioning current become less. A reduction in 
the DAP results in decreased superexcitability. During this time, there may be short period of 
paraesthesiae in sensory axons, as an increase in Nap activity predominates. After the release 
of ischaemia, the opposite changes occur with a return of pump function, with an apparent 
rebound in all excitability parameters and a period of relative membrane hyperpolarisation. 
During this phase, there is a reversal of the usual electrochemical gradient of K
+
, such that K
+
 
channels start to become regenerative as they become inward and depolarising. There are 
spontaneous depolarisations towards Ek which produce bursts of action potentials if ischaemia 
is prolonged. Then the axon appears to enter two states of both depolarisation and 
hyperpolarisation after release of the cuff. A minority of depolarised axons then return to the 
hyperpolarised state, and generate ectopic potentials in doing so (Bostock et al., 1991). 
A special consideration is warranted regarding the finding of changes of membrane 
depolarisation in excitability studies. Although the effects of ischaemia have been studied 
above in the experimental condition and conclusions drawn regarding similar changes in 
studies of chronic neuropathic conditions in the literature, one has to be cautious about the 
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interpretation of these results in chronic neuropathy as being necessarily due to chronic 
ischaemia. Various factors may be important in the chronic condition such as compensatory 
mechanisms, not to mention the chronic effects on downstream processes such as the Na
+
-Ca
+
 
exchanger (see before). This may well be the reason why the findings in Chapter 4D were 
negative (see later).  
Maximal voluntary contraction 
Vagg reported that natural maximal voluntary contraction (MVC) can produce 
hyperpolarisation in motor axons, the extent of which depends on the length of the 
contraction period (Vagg et al., 1998). For example, the threshold of motor axons increases by 
approximately 40% for 15 mins after MVC for 1 minute. The Na
+
-K
+
 pump is likely to be 
responsible for this in similar ways as outlined before with impulse trains of a prolonged 
duration. Therefore, this technique has been used to indirectly assess pump function in a 
number of disorders. In normal axons, following maximal contraction, the refractory period of 
transmission is impaired distal to the stimulation site and likely maximally at terminal branch 
points (Kuwabara et al., 2001). The effect of these manoeuvres is not the same in different 
nerves (Kuwabara et al., 2002). 
This manoeuvre has been shown to precipitate conduction block in demyelinated axons 
(Cappelen-Smith et al., 2000, Cappelen-Smith et al., 2001). However, it has not been shown to 
be the reason that axons fail in carpal tunnel lesions for motor (Cappelen-Smith et al., 2003) or 
sensory axons (Kiernan et al., 1999). This led workers to believe that the safety margin for 
conduction (estimated at 5 x) is not compromised in mild to moderate carpal tunnel syndrome, 
and that demyelination may not be important in that condition. In diabetic neuropathy, there 
was reduced threshold change with MVC, along with slower recovery implying Na
+
- K
+
 pump 
dysfunction, as well as a reduction in nodal Na
+
 currents (Krishnan and Kiernan, 2005). The 
latter was inferred because of a reduction in τSD and refractoriness. In contrast, no changes 
were seen in end-stage kidney disease, implying that that the Na
+
-K
+
 pump was not impaired 
(Krishnan et al., 2006).  
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Modelling 
Models have been developed from work in human and mammalian axons to mathematically 
infer the contributions of the constituent components (ion channels, capacitance, pumps, 
resistances) that are important to axonal excitability. For the most part, the models 
incorporate these components with simplified axonal geometry. To begin with, Bostock 
developed a model of a single human motor axon, based on data derived from lizard and frog 
axons. Intra- and extracellular  rat spinal root (Baker et al., 1987) recordings, and current and 
voltage clamping of nodal currents in human nodes (Scholz et al., 1993, Schwarz et al., 1995, 
Reid et al., 1999) were then used to reproduce the AP and saltatory conduction. For this to 
occur, a simple model of the properties of the transient Na
+
 channel alone  appeared to be 
sufficient.  However, the model did not cope well with depolarised nodes, or with the effects 
of ischaemia and impulse activity (Bostock et al., 1998). The addition of the subthreshold 
behaviour of Na
+
 channels and a small Nap current (Bostock and Rothwell, 1997) derived from 
later experiments such as latent addition, has contributed to a more refined model that 
includes persistent and transient Na
+
 currents, fast and slow K
+
 channels, and single form of 
the inward rectifier, Ih. The result is a space-clamped, two compartment electrical circuit (Fig. 
1.6) of a node and paranode linked by Barrett and Barrett currents running through and under 
myelin with components of myelin capacitance, leak conductances and the Na
+
-K
+
 pump. This 
model can account for the changes in threshold electrotonus and strength-duration behaviour 
when nerves are depolarised or hyperpolarised.  
As with any model, there are limitations to the inferences one can make as it is developed and 
refined from components derived in individual experiments, in this case, not limited to human 
studies. Further, the modelling paradigm is also subject to the mathematical construct (for 
example, the degree of weighting for each of the components of excitability testing) and the 
number of variables that can be deduced to have altered to give rise to a result. Nevertheless, 
as proof of concept, an important study on human subjects poisoned with tetrodotoxin 
demonstrated that the model could faithfully reproduce the changes seen in these individuals 
by reducing the Na
+
 permeability by a factor of 2 (Kiernan et al., 2005). 
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Recently, a model has been developed also for human sensory axons with its different set of 
properties, some of which have been already been described above (Howells et al., 2012). 
Using an unclamped mode which allowed secondary changes to occur as a result of 
polarization from alterations in currents, MEMFIT function was employed using Qtrac software 
(Bostock, 2006) to apply to results collected from 10 healthy individuals. Modelling in this 
experiment was based on fitting an extended Trond protocol introduced by Tomlinson et al. 
(Tomlinson et al., 2010), because the original Bostock model provided a poor fit for the 
responses to longer and stronger hyperpolarisation. The model employed a least squares 
method, which minimises the error between the model and the average data. A weighting of 
the four components in the Trond protocol were given to the following: strength duration, 0.5; 
threshold electrotonus, 3; current threshold, 1; and recovery cycle 1. Unitary changes were 
performed first to conductances, currents or pump before moving on to more elaborate 
iterations incorporating combinations. The model was first optimised for the motor study 
results from this cohort, and then applied to the sensory data of the same. This study 
produced some important findings that challenged previous notions of the differences 
between motor and sensory axons (Howells et al., 2012). First of all, the model pointed to a 
greater activity of Ih currents in sensory axons, which was mostly explained by a depolarising 
shift in the voltage activation of Ih, and to a lesser extent, an increased maximal conductance.  
This could have been brought about by a larger proportion of open ‘fast’ HCN isoforms at rest 
in sensory axons, and a larger proportion of ‘slow’ HCN isoforms at rest in motor axons. 
Secondly, there was a reduced expression of slow K
+
 channels in sensory axons. Thirdly, the 
RMP of sensory axons (~81mV) appears to be more depolarised than for motor axons (~84-85 
mV). Importantly, this could be driving more current through Nap in its resting state in sensory 
axons, and therefore, there may actually be no difference in the expression of that channel 
between sensory and motor axons. 
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Figure 1.6. Simplified mathematical model of the myelinated axon with the principal 
components at the node and internode 
 
Voltage-gated channels: sodium (transient (Na) and persistent (Nap)); potassium (fast (Kf) and slow (Ks)); 
HCN (H); Na
+
/K
+
-ATPase pump (Ipump); ohmic leak conductance (Lk); capacitance of: axolemma 
(internodal (Cax), nodal (Cn)), myelin sheath (Cm); Barrett–Barrett conductance (RB−B) through and under 
the myelin sheath. Reproduced from Howells et al (Howells et al., 2012). 
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Part B  Changes in peripheral nerve function in peripheral 
nerve diseases 
Introduction 
A summary of the changes in nerve excitability studies in humans reported in the literature 
using the automated Trond protocol is given in the table (see Table 1.3). Overall, the changes 
in excitability that have been noted in these diseases could also be classified under: 
Altered membrane potential 
Axonal depolarisation – renal failure (Kiernan et al., 2002), critical illness 
polyneuropathy (Z'Graggen et al., 2006), porphyria (Lin et al., 2008), Fabry disease 
(Tan et al., 2005), lead poisoning (Krishnan et al., 2012), prediabetic neuropathy 
(Arnold et al., 2013). 
Axonal hyperpolarisation – excess carbonated water consumption (Kuwabara et al., 
2002, Krishnan et al., 2005), multifocal motor neuropathy(Kiernan et al., 2002), 
inclusion body myopathy, Paget’s disease, frontotemporal dementia (IBMPFD) (Kumar 
et al., 2011), myotonic dystrophy (Krishnan and Kiernan, 2006), Kennedy’s disease 
(Vucic and Kiernan, 2007). 
Abnormal ion channel function and availability 
Na
+
 channels – diabetes mellitus (Kitano et al., 2004, Misawa et al., 2004, Krishnan and 
Kiernan, 2005), oxaliplatin (Park et al., 2009), tetrodotoxin (Kiernan et al., 2005), 
amyotrophic lateral sclerosis (ALS) (Mogyoros et al., 1998), familial amyotrophic lateral 
sclerosis (fALS) (Vucic and Kiernan, 2010), spinocerebellar ataxia (SCA) type 3 (Kanai et 
al., 2003), SCN1β – generalized epilepsy with febrile seizures plus (GEFS+) (Kiernan et 
al., 2005). 
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K
+
 channels – ALS (Cheah et al., 2012), neuromyotonia (Kiernan et al., 2001), Charcot 
Marie Tooth (CMT) type 1a (Nodera et al., 2004) with morphological changes, benign 
neonatal familial convulsions (BNFC) (Tomlinson et al., 2012). 
Ih channels – diabetes mellitus (Horn et al., 1996), cortical stroke (Jankelowitz et al., 
2007), acute porphyria without neuropathy (Lin et al., 2008). 
Abnormal Na+-K+ ATPase pump function 
Diabetes mellitus (Kuwabara et al., 2002), acute porphyric neuropathy (Lin et al., 
2008). 
Most of these studies compared results in patients with disease against normal control 
subjects, using group-to-group comparison of mean values via parametric and non-parametric 
tests of significance. Few looked at the sensitivity of tests, both of standard NCS and the 
relatively novel technique of nerve excitability employed, to detect a clinical neuropathy. 
Although there is little doubt regarding the ability of nerve excitability techniques to 
demonstrate a pathophysiological alteration or abnormality of axons, there are few studies 
looking at its sensitivity and its correlation with established clinical indicators of neuropathy 
and how these new methods compare with standard nerve NCS parameters. 
To investigate this, three conditions with peripheral neuropathy that have not been evaluated 
thus far with automated nerve excitability techniques were studied in this thesis. These were 
end-stage liver disease, human immunodeficiency virus (HIV) infection (with both viral distal 
sensory and anti-retroviral drug related polyneuropathy), and mitochondrial disease.  
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Table 1.3. Summary of excitability changes in studies with the Trond protocol 
Neurological disorder  Lead author Year SDTC TE RC Interpretation Explanation/notes 
        
renal  Kiernan 2002 ↑ fan in 
↑ ref  
↓ super  
↓ sub 
depol 
high [K
+
]e stim 
Na
+
-Ca
2+
 exchanger 
renal - ischaemic  Krishnan 2006   
  
paradoxical postisch 
↓ in excit 
Na
+
-K
+
 pump works well 
hypoK
+
/ 
carbonated drink 
Kuwabara 2002 ↓ fan out 
↓ ref  
↑ super  
↑ sub 
hyperpol hyperpol from low K
+
 
hypoK
+
/ 
carbonated drink 
Krishan 2005 ↓ fan out 
↓ ref  
↑ super  
↑ sub 
hyperpol hyperpol from low K
+
 
diabetes Kuwabara 2002 
 
fan in 
 
↓ Na
+-
-K
+
 pump 
activity-dependent  
changes also 
diabetes Kitano 2004 ↓ fan in 
↓ all 
parameters 
↓ Na
+
 
activity-dependent  
changes also 
diabetes Krishnan 2005 ↓ fan in  
↓ all  
parameters 
↓ Na
+
 
 
diabetes Horn  1996   
  
↓ Ih 
mainly sensory  
PreTrond study 
diabetes Misawa 2004 
  
↓ ref ↓ Na
+
 inactivation 
 
diabetes Misawa 2006 
↓ using 
LA   
↓ Na
+
 
glucose effect -  
Na
+
 gradient and Nap 
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Table 1.3 (cont’d) 
Neurological disorder 
Lead author Year SDTC TE RC Interpretation Explanation/notes 
        
diabetes pre- 
neuropathy 
Arnold 2013 
 
fan in  
↑ ref  
↓ super    
depol study of type 1 and 2 DM 
paclitaxel Park 2011 n n n normal excit 
 
oxaliplatin Park 2011 n n 
↓ ref motor 
↑ref sensory 
↓ Na
+
 in sensory 
 
oxaliplatin 
longitudinal 
Park 2011 
   
no change in sensory 
 at 25 months 
no reversibility 
TTX Kiernan 2005 ↓ 
↓ TEd 
↑ TEh 
↓ all 
parameters 
Na
+
 channel blockade 
modelled by  
↓ Na
+
 conductances by 2 x 
critical illness 
polyneuropathy 
Z'graggen 2006 n fan in  
↑ ref 
↓ super  
↓ sub 
depol 
depol becos of raised K
+
 and 
also hypoperfusion 
Fabry Tan 2005 
 
fan in  ↓ super depol   isch 
porphyria Lin  2008 
   
Na
+-
K
+
 pump in neuropathy 
↓ Ih with neurotoxin 
mainly sensory study 
porphyria Lin 2009 
 
fan in ↑ ref   depol 
↓ Na
+
-K
+
pump, improved 
 heme arginate/glucose 
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Table 1.3 (cont’d) 
Neurological disorder  
Lead author Year SDTC TE RC Interpretation Explanation/notes 
        
lead poisoning –  
one patient 
Krishnan 2012 
 
↓ TEd ↑ ref depol ↑ changes with isch 
ALS Bostock 1995 
   
↓K
+ 
cond will cause  
↑ excit 
  
ALS Mogyoros 1998   
  
ischaemic resistance 
different to diabetes 
  
ALS Mogyoros 1999 ↑motor  
 
n ↑ Nap 
could contribute  
to ectopic activity 
ALS Kanai 2006 
↑ 
in normal 
CMAP 
fan out ↑ super normal excit 
 
ALS Vucic 2006 ↓ fan out ↑ super normal excit 
 
ALS - longitudinal Cheah 2012 
 
↑ TEd 
↑ super 
with time 
K
+
 channel dysfunction 
 
ALS - split hand Shibuya 2013 
↑ 
APB>ADM   
higher excit in median 
than ulnar axons  
fALS SOD1 Vucic 2010 ↑ 
  
↑ Nap correlated with ↓SICI  
AMAN Kuwabara 2002 n n ↑ ref distal conduction failure 
 
Kennedy Vucic 2007 ↑ ↑ TEd 
 
membrane hyperpol 
 
Hirayama Sawai 2011 ↑ fan out 
↑ ref and 
super   
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Table 1.3 (cont’d) 
Neurological disorder  
Lead 
author 
Year SDTC TE RC Interpretation Explanation/notes 
        
MMN Kiernan 2002 n 
fan out and 
↑slope 
↑ super hyperpol 
hyperpol from  
nearby depol lesion 
MMN Lin 2013 
    
reversal of above with IVIG 
MMN Cheah 2002 n n n 
no abN at sites remote 
disease less than 6 yrs  
neuromyotonia Kiernan 2001 n 
↑overshoot, 
TE accom 
↑ sub ↑ slow K
+
 ectopic activity mediated 
IBMPFD Kumar 2010 n fan out 
↓ ref ↑super  
in motor 
hyperpol overactive Na
+-
-K
+
 pump 
SMA Farrar 2011 ↑ 
fan out 
esp early 
phase 
  
mixed degen/regen  
on modelling 
CTS 
Cappelen-
Smith 
2003 
   
no activity- 
dependent block  
CTS with focal 
compression 
Han 2011 
   
depol more 
marked in CTS 
more Na
+
-K
+ 
pump 
dysfunction 
CTS with arm 
ischaemia  
Cheah 2009 
  
ref ↑ with isch 
dysfunction 
adapting to isch  
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Table 1.3 (cont’d) 
Neurological disorder  
Lead author Year SDTC TE RC Interpretation Explanation/notes 
        
CTS  Kiernan 1999 
   
changes of depol block 
with wrist ext 
isch compression  
from CTS 
CIDP  Sung 2004 
 
fan out n morphological changes   
CIDP 
Cappelen-
Smith 
2001 ↓ n 
↓ all 
parameters 
morphological changes   
CIDP - MVC 
Cappelen-
Smith 
2000 
    
acitivity-dependent block 
CIDP - IVIG Lin 2011 
↓ with 
IVIG 
fan in  
with IVIG 
↓ super/sub 
with IVIG 
IVIG stabilises membranes 
 
CMT1a Nodera 2004 n fan out 
↓ ref 
↓ super 
↑ fast K
+
 conductance   
CMT1X Liang 2013 n fan out ↓ ref modelled morphological changes 
HNPP Jankelowitz 2013 n fan out n Structural myelin changes redistributed K
+
 channels 
GBS Kuwabara 2003 
   
impaired refractory period 
of transmission  
GBS Kuwabara 2002 
 
n 
ref ↑ in 
AMAN not 
AIDP 
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Table 1.3 (cont’d) 
Neurological disorder  
Lead author Year SDTC TE RC Interpretation Explanation/notes 
HSP (SPG4) Kumar 2011 ↑ motor n n normal excit 
normal excit even with 
abnormal NCS 
SCA3 Kanai 2003 n n n ↑ Nap tried mexiletine ↓ cramp 
myotonic dystrophy Krishnan 2006 n fan in  ↑ ref  hyperpol   
hemifacial spasm Krishnan 2007 n n n normal excit ? ↑ excitability facial nerve 
SCI Lin 2007 ↓ fan in ↓ sub 
decentralization and 
consequent inactivity 
uncertain 
SCI Boland 2009 
 
fan in 
↑ ref 
↓ super 
decentralization and 
consequent inactivity 
modelling suggested  
Na
+-
-K
+
pump 
GEFS+ Kiernan 2005 ↓ ↑ TEh ↓ ref ↓ Na
+
 
 
BNFC (Kv7.2) Tomlinson 2012 
 
↑ TEd  
↓undershoot 
↓ ref 
↑ super  
↓ sub 
↓ slow K
+
 
upregulation of 
other types of K
+
 
EA2 Krishan 2009 n ↓ early TE 
↑ ref 
↓ sub 
indirect effects on KCNQ 
channels  
EA1 (Kv1.1) Tomlinson 2010 
 
fan out ↑ super Kv1.1 effect 
 
stroke - cortical  Jankelowitz 2007 
 
↓ Ih 
 
modulation of Ih by activity 
 
 
Legend: abN = abnormality; AIDP = acute inflammatory demyelinating polyneuropathy; ALS = amyotrophic lateral sclerosis; AMAN = acute motor axonal neuropathy; amp = amplitude; BNFC = benign neonatal 
familial convulsions; CIDP = chronic inflammatory demyelinating polyneuropathy; CMT = Charcot Marie Tooth; CTS = carpal tunnel syndrome; depol = depolarisation; DM = diabetes mellitus; EA = episodic ataxia; 
excit = excitability; fALS = familial ALS; GBS = Guillain-Barre syndrome; GEFS+ = generalised epilepsy with febrile seizures +; HSP = hereditary spastic paraplegia; hyperpol = hyperpolarisation; IBMPFD  = inclusion 
body myopathy, Paget’s disease, frontotemporal dementia; Isch = ischaemia, ischaemic; IVIG = intravenous immunoglobulin; LA = latent addition; MMN = multifocal motor neuropathy; MVC = maximal voluntary 
contraction; n = normal; NCS = nerve conduction studies; Ref = refratoriness; rheo = rheobase; RRP = relative refractory period; SCA = spinocerebellar ataxia; SCI = spinal cord injury; SDTC = strength-duration time 
constant; SICI = short intracortical inhibition; SMA = spinal muscular atrophy; SOD = superoxide dismutase; sub = subexcitability; super = superexcitability; TE = threshold electrotonus; TEd = depolarising threshold 
electrotonus; TEh = hyperpolarising threshold electrotonus; TTX = tetrodotoxin 
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Peripheral neuropathy in end–stage liver disease 
The presence of neuropathy in patients with severe liver disease has been known for some 
time. This type of neuropathy is generally mild with a few notable exceptions (Spahn et al., 
1995, Gane et al., 2004). These two reports describe considerable motor dysfunction in 
individuals, which reversed when the patients recovered with organ transplantation. Co-
morbidities such as alcoholic polyneuropathy and infectious hepatitis (and its associated 
vasculitic neuropathy) muddy the picture, but there appears little doubt that there is an 
association of peripheral neuropathy with end-stage liver disease, with multiple reports of 
somatic (Gentile et al., 1993, Chaudhry et al., 1999, McDougall et al., 2003) and autonomic 
dysfunction (Hendrickse and Triger, 1993, Dillon et al., 1994, Chaudhry et al., 1999, Trevisani et 
al., 1999, McDougall et al., 2003). Most studies in the literature report a reduction in 
amplitudes and conduction velocities of sensory and motor nerves on nerve conduction. 
The association of neuropathy and liver failure prevails despite considerable debate regarding 
the confounding entities of alcoholic neuropathy and nutritional deficiency (Mellion et al., 
2011). To add to the difficulty, chronic alcoholism also causes autonomic dysfunction. Primary 
biliary cirrhosis, an autoimmune condition is also associated with a demyelinating sensory and 
autonomic neuropathy (Kempler et al., 1994, Keresztes et al., 2004).  
The prevalence of somatic neuropathy varies between 39-93%, with small fibre dysfunction in 
28-60%, even when other possible co-morbidities are excluded (Gentile et al., 1993, Chaudhry 
et al., 1999, McDougall et al., 2003). Chaudhry and Gentile reported different prevalence rates 
of small fibre dysfunction (Gentile et al., 1993, Chaudhry et al., 1999). However, Chaudhry et 
al. studied only cool detection using a Case IV model (WR Medical Electronics Co., MN, USA) 
device. Gentile et al. used the forced choice algorithm which may account for the lower 
prevalence of neuropathy in that study. There appear to be no studies of epidermal nerve fibre 
density (ENFD) or morphometry from skin biopsies in this condition.  
Some of these studies have also addressed the reversibility of these changes after successful 
organ transplantation, especially that of autonomic dysfunction (Mohamed et al., 1996, 
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McDougall et al., 2003). This is important because autonomic dysfunction has been noted in 
half of all studies, and is an independent predictor of mortality (Hendrickse et al., 1992, Dillon 
et al., 1994, Chaudhry et al., 1999, Trevisani et al., 1999, McDougall et al., 2003). 
Parasympathetic dysfunction is the commonest autonomic manifestation, perhaps supporting 
a length-dependent affliction, akin to the somatic form. There have also been 
histopathological studies which document segmental demyelination, thinly myelinated nerves 
and axonal loss in hepatic neuropathy (Dayan and Williams, 1967, Knill-Jones et al., 1972, Chari 
et al., 1977, Chopra et al., 1980).  
A toxic pathophysiological mechanism is popular, and Sherlock postulated that an 
unmetabolized endogenous neurotoxin could be responsible in her standard textbook 
‘Diseases of the Liver and Biliary System’ (Sherlock, 1968). Kardel proposed that ‘toxic 
inhibition of the nerve axon membrane function.. would result in.. a reduction of the 
electromotive force of the axon membrane potential’  and that this toxin may somehow 
reduce the membrane potential via toxic inhibition of cellular oxidative metabolism (Kardel 
and Nielsen, 1974). In early excitability studies in this condition, Seneviratne and Peiris found a 
resistance to ischaemia, even in the absence of standard sensory NCS abnormalities 
(Seneviratne and Peiris, 1970). These findings are somewhat similar to those that are well 
characterised in diabetic neuropathy, and have been linked to reduced Na
+
-K
+
 ATPase pump 
function (Scarpini et al., 1993).  
A state of nerve hyperexcitability in hepatic neuropathy is suggested by the prevalence of 
muscle cramp (Abrams et al., 1996, Angeli et al., 1996), which may have a basis in reduced 
intravascular perfusion. In liver disease, Angeli et al. stated “an alteration of the neural cell 
membrane excitability may be suggested as a consequence of hypoperfusion”. Cramp is a 
frequent symptom in motor neuropathies, and conditions such as neuromyotonia also have 
cramp as a prominent feature. However, although neuromyotonia has been studied with the 
Trond protocol, no primary abnormalities were found, presumably because the ectopic activity 
arises from sites remote from the site of stimulation (Kiernan et al., 2001).  
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The changes of membrane depolarisation as seen in experiments using acute ischaemia 
(Kiernan and Bostock, 2000) appear to be different to the excitability profile that was 
documented in amyotrophic lateral sclerosis (ALS), another motor neuronopathy 
chararacterised by prominent cramp. In ALS, there were instead increased threshold changes 
in electrotonus (Kanai et al., 2006, Vucic and Kiernan, 2010). Another mechanism of ischaemia 
is seen in Fabry disease. Axonal depolarisation was revealed, presumably as a result of 
endoneurial ischaemia resulting from poor nerve perfusion. This may have arisen from 
ceramide trihexoside deposition in the endothelial, perithelial cells and smooth muscle cells of 
the endoneurial vessels (Tan et al., 2005). Perhaps, similar changes may be seen in hepatic 
neuropathy, and this condition is explored in Chapter 4A with excitability techniques. Having 
noted that the intra-individual variability in excitability testing is low (Tomlinson et al., 2010), 
the reversibility of any findings post-transplant will be studied in Chapter 4B. 
 
HIV-associated peripheral neuropathy – Distal sensory 
polyneuropathy and antiretroviral agent - associated variants 
The human immunodeficiency virus (HIV) affects approximately 40 million people worldwide, 
creating a large socioeconomic and medical burden (McArthur et al., 2005). Considerable 
progress has been made in longevity with a myriad of antiretroviral agents now available, but 
there are still several ways in which the PNS may be affected. These include 
mononeuropathies (both viral and vasculitic), plexopathies, motor neuropathy, acute and 
chronic inflammatory neuropathies (Guillain-Barre syndrome and CIDP), polymyositis and 
diffuse infiltrative lymphomatosis. Although CNS complications appear to be declining due to 
more effective highly active anti-retroviral therapy (HAART), PNS complications are still 
common and may actually be on the rise (Cornblath and Hoke, 2006).  
An estimated 36% of those with advanced HIV are affected by peripheral neuropathy, as 
determined using conventional neurophysiological techniques (Iragui et al., 1994, Schifitto et 
al., 2002), many painfully so. There are two main forms of peripheral neuropathy and they 
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both manifest primarily as predominantly sensory processes. Most patients suffer a distal 
symmetrical polyneuropathy (DSP). This condition appears to be related to viral disease load. 
Since the use of combination antiretroviral therapy in the mid-1990s, the incidence of 
neurological complications has fallen dramatically. However, a neuropathy can arise from 
highly active antiretroviral therapy (HAART). This is termed antiretroviral (ARV) neuropathy 
here, and it is caused by the use of older dideoxynucleoside antiretroviral agents such as 
didanosine (ddI), stavudine (d4T) and zalcitabine (ddC). These agents are potent inhibitors of γ-
DNA polymerase, in contrast with other drugs in the same class, zidovudine, lamivudine and 
abacavir, which have limited effect on this enzyme and do not cause neuropathy (Martin et al., 
1994). ARV neuropathy continues to be an important cause of peripheral neuropathy in 
patients treated with these drugs in resource-poor developing countries, especially d4T. Some 
investigators believe that antiretroviral agents may also ‘unmask’ a DSP as the effect on the 
mitochondrial system may exacerbate what was hitherto a subclinical process (Nakamoto et 
al., 2010). Nevertheless, most workers agree that they are separate entities 
pathophysiologically, though differentiation can be difficult on clinical grounds, even with 
modern laboratory methods, as they may be phenotypically identical.  
There are several risk factors that predispose to HIV DSP. Older studies indicate that 30% of 
patients hospitalised with AIDS had DSP without a contribution from antiretroviral agents, 
using clinical and electrophysiological techniques (Levy et al., 1985). This is in stark contrast to 
a rate of 3% in less advanced cases  with a CD4 count of < 200 x 10
6
/L (Barohn et al., 1993). 
There is a recorded incidence rate of 7% in those with CD4 counts < 10
6
/L (Bacellar et al., 
1994). Other risk factors include older age, nutritional deficiencies, alcohol use, presence of 
diabetes mellitus, white race, HIV ‘set-point’, and a low CD4 count (Lichtenstein et al., 2005, 
Simpson et al., 2006).  
Clinically, patients with both neuropathies complain of dysaesthetic sensations with aching 
and burning. Hyperalgesia and allodynia are frequent. Weakness is rare and usually confined to 
the intrinsic muscles of the foot. One often has to resort to the timing of a culpable 
antiretroviral agent to surmise cause and effect. Standard NCS normally reveal a length-
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dependent sensory axonal neuropathy. There are also documented abnormalities of small 
fibre function, including ENFD (McArthur et al., 2005). Histology indicates a length-dependent 
sensory neuropathy of both myelinated and unmyelinated nerves. A dying-back hypothesis is 
supported by degeneration of the rostral gracile tract, the CNS counterpart of peripheral 
degeneration (Cavanagh, 1964, Rance et al., 1988).  
The pathogenesis of HIV DSP is thought to be related to inflammatory processes centred on 
the DRG. Virus is co-localised in the perivascular inflammatory cells. The envelope 
glycoprotein, gp120, as well as inducing apoptosis in rat dorsal root ganglion (DRG), lowers the 
threshold for excitation in-vivo (Oh et al., 2001). Pro-inflammatory cytokines including TNFα, 
IL-6, interferon -α and nitric oxide have been found in high concentrations in the DRG, and in 
animal models have been shown to lead to upregulation of sodium channels and neuronal 
hyperexcitability in the DRG (Choi et al., 2008). There are both peripheral and central 
sensitisation mechanisms. Spontaneous activity is present in C fibres (Pardo et al., 2001), and 
loss of unmyelinated fibre input into the lamina II of the substantia gelatinosa of the cord 
predisposes to ingrowth of A-fibres and aberrant wiring (Baba et al., 1999, Choi et al., 2008). 
Several HIV proteins (Vpr, Vpu, Tat ) can alter ion channel conductances through the formation 
of new channels (viropores), or the modulation of existing gates, such as, for example, in the 
effects of on Vpu1 on K2P3 channels which regulate K
+
 leakage and thereby excitability (Plant 
et al., 2005, Choi et al., 2008). 
Prominent mitochondrial abnormalities have been seen after exposure to nucleoside reverse 
transcriptase inhibitors, especially d4T, ddI and ddC. There may also be a risk from combined 
protease inhibitors (Pettersen et al., 2006). The finding is supported by elevated lactate 
concentrations and reduced acetylcarnitine in serum. It has been surmised from separate in 
vitro observations that there is a graded inhibition of γ-DNA polymerase by these agents, as 
well as a reduction in mitochondrial DNA copy numbers (Martin et al., 1994). In addition to the 
above, there is inhibition of neuritic growth by the offending agents (Keswani et al., 2003).   
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In summary, there appears to be a gp 120-mediated neurotoxicity which is predominantly 
apoptotic and mediated via Schwann cells in DSP, and a neuronal necrotic process in toxic ARV 
neuropathy. Axonal excitability would hopefully be able to differentiate these two different 
kinds of neuropathy because of their supposed different pathophysiological mechanisms. DRG 
hyperexcitability and Na
+
 channel upregulation cannot be tested directly, but there may be 
more distal effects, either from the inflammatory process or from a Wallerian degenerative 
effect. The toxic effects of antiretroviral drugs that have been implicated in neuropathy may be 
more easily assessed with the present peripheral excitability methods, as the enzymic 
disturbance in neuronal cells is probably distributed along the axon much as mitochondria are. 
Therefore, an effect suspicious for paralysis of the Na
+
-K
+
 pump may be observed. This would 
allow the differentiation of these two neuropathies on neurophysiological grounds. The clinical 
implications of this would be important, as the management is quite different for these two 
conditions. HIV DSP usually does not warrant a change in antiretroviral agents in the clinical 
setting because that is unlikely to affect the clinical outcome. Instead, pain-combative 
strategies are important. Nerve regenerative strategies are still being studied. In contrast, 
findings suggestive of ARV neuropathy should prompt a change of the HAART regimen, if 
possible. 
 
Peripheral neuropathy in mitochondrial diseases 
Mitochondrial disorders are multisystem diseases that have protean manifestations. The 
human mitochondrial DNA (mtDNA) is a 16,569 base pair double-stranded molecule that 
contains 37 genes. Over time, mitochondria have lost their autonomy such that many of their 
functions are heavily reliant on the nuclear genome. For inherited disorders, the mitochondrial 
disorders are over-represented for the amount of genetic material in mtDNA, but nuclear DNA 
(nDNA) abnormalities encoding for mitochondrial function also fall within this rubric. In fact, 
nDNA encodes for all but 13 of the 80 or so proteins that make up the respiratory chain. 
MtDNA defects are passed  from an affected female to all her progeny while nDNA defects 
follow Mendelian inheritance. The mtDNA defects can be divided into point mutations (e.g. 
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MELAS, MERFF, NARP, LHON, see below in full), or deletions/duplications (e.g. Pearsons, CPEO, 
KSS, see below in full)(DiMauro and Schon, 2003).  
Although a deficiency of the respiratory chain appears to be the common defect, the effect of 
disease on various organs including the nervous system is quite diverse. Not only can there be 
large variations within a particular syndromic disorder, private mutations can harbour 
markedly heterogenous presentations even within the same family. Healthy wild-type 
mitochondria are normally homoplasmic, meaning they are all identical within a cell line. 
Heteroplasmy denotes that only some of the mitochondria may be abnormally affected, and it 
is the relative fraction of abnormal mitochondria to healthy ones that affects how that 
disorder may manifest in a certain organ. In addition to this, with cell division, the proportion 
of mutant mtDNAs in daughter cells can shift and the phenotype can change, and this may be 
evident in a single patient as s/he grows older (DiMauro and Schon, 2003). Due to a lack of 
animal models, the biochemical and functional consequences of mtDNA mutations have been 
studied from cell lines that have been emptied of their normal mitochondria and repopulated 
with mutant DNA from patients (King and Attardi, 1989). Such ‘cybrid’ cell lines have been 
shown in vitro to possess thresholds for pathogenicity that may be as high as 90%. This may 
not be the case in vivo, where dysfunction can be seen in oligosymptomatic carriers (Chinnery 
et al., 2000). 
Metabolically, reducing equivalents produced in the Krebs cycle and in β-oxidation are passed 
along a series of proteins that are embedded in the inner mitochondrial membrane which is 
known as the electron transport chain. These consist of 4 multimeric complexes (I-IV) and 2 
electron carriers, coenzyme Q and cytochrome c. Protons are pumped from the mitochondrial 
matrix into the space between the inner and outer membranes, generating a gradient which is 
utilised by ATP synthase (complex V) to produce ATP in oxidation/ phosphorylation coupling. 
The two most common pathogenic mechanisms felt to be important in mitochondrial disorders 
are lack of ATP synthesis, and an excess of reactive oxygen species (DiMauro and Schon, 2003).  
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The effect of a mitochondrial disorder is felt most acutely in organs that have a high metabolic 
rate. These include skeletal and cardiac muscles, peripheral nerves and the CNS. The 
prevalence of neuropathy varies between 22 to 77% according to the type of mitochondrial 
disorder (Yiannikas et al., 1986, Bouillot et al., 2002, Karppa et al., 2003, Kaufmann et al., 
2006). The affliction of nerves can be of axonal or demyelinating type, or both. Broadly 
speaking, there are several types of mitochondrial disorder but their peripheral neuropathy 
can be classified into the following groups: (i) conditions where neuropathy is a primary 
feature and predominates; (ii) conditions where neuropathy is an inconstant feature; and (iii) 
conditions where neuropathy is consequence of another medical state caused by 
mitochondrial disease (Finsterer, 2011). The following is a list of some disorders by this 
classification.  
Peripheral neuropathy predominates 
Syndromic  - neuropathy, ataxia, retinitis pigmentosa syndrome (NARP)  
Non-syndromic - CMT2A, CMT2K, CMT4A, severe mixed axonal/demyelinating sensori-
motor neuropathy with progressive external ophthalmoplegia (PEO) 
Peripheral neuropathy is a collateral feature 
Syndromic – mitochondrial encephalomyopathy, lactic acidosis, and stroke-like 
episodes syndrome (MELAS), myoclonus epilepsy with ragged-red fibers (MERRF), 
Leber’s hereditary optic neuropathy (LHON), Kearn-Sayre syndrome (KSS), Mendelian 
PEO, Leigh syndrome, mitochondrial neurogastrointestinal encephalomyopathy 
(MNGIE), sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO), etc. 
Non-syndromic - diseases without acronyms but peripheral neuropathy as one among 
other manifestations 
Secondary peripheral neuropathy 
Neuropathy may be secondary to diabetes, renal insufficiency, hypothyroidism, 
hyperthyroidism, hypoparathyroidism, or a paraneoplastic disorder. 
 
Chapter 1- Literature review 
 
60 
Mitochondrial abnormalities are present in peripheral nerve in almost all patients with 
mitochondrial disease  in their large and small myelinated and unmyelinated axons (Schroder, 
1993). However, the abnormalities are more frequent in Schwann cells, and in the endothelial 
and smooth muscle cells of the vasa nervorum (Schroder, 1993). Nevertheless, there is little in 
the literature on peripheral nerve function apart from nerve conduction abnormalities.  
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome 
(MELAS) 
This disorder is maternally inherited, occurs in young people, and consists of stroke-like 
episodes that do not conform to vascular territories(Hirano et al., 1992). In most families, only 
one individual will have MELAS syndrome and the rest will be oligo- or asymptomatic. Other 
features that may be present are tonic-clonic seizures, migraine-like headache, confusional 
states, dementia, psychosis, deafness, short stature, recurrent vomiting, and peripheral 
neuropathy (Goto et al., 1990). About 80% of cases have a heteroplasmic transition of 
m.3243A>G in the tRNA Leu gene. The other most frequent causes are m.3271T>C and 
m.3252A>G in the transcription terminator. There are many reports of neuropathy as an 
inconstant condition in this disorder (Rusanen et al., 1995, Chu et al., 1997, Klimek et al., 1997, 
Karppa et al., 2003) and it may be a subclinical manifestation in some. It is commonly a mixed 
axonal and demyelinating disorder affecting motor and sensory fibres. Motor affliction is more 
frequent than sensory (Karppa et al., 2003). Occasionally, a pure demyelinating phenotype 
may be seen, such as in a single patient where the heteroplasmy rate was 29% for m.3243A>G 
mutation. However, on the whole, phenotypic correlation with heteroplasmy rate is weak 
(Karppa et al., 2003). 
The neuropathy in mitochondrial disorders can manifest its features via defects in the 
respiratory chain. Prior to the studies in this thesis, excitability studies on mitochondrial nerves 
and neuropathy had not been reported except in a single 10-year old patient with MELAS in a 
crisis (Farrar et al., 2010). The changes seen in this individual were consistent with acute 
reversible axonal energy failure. Axonal excitability could reasonably be expected to be 
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abnormal in patients because the failure of energy-dependent systems may produce evidence 
of axonal depolarisation. Therefore, excitability techniques may be able to prove or refute an a 
priori hypothesis that the axons of afflicted individuals will be depolarised or predisposed to be 
depolarised through an ischaemic mechanism.  
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Part C Indirect effects on neuronal excitability 
Changes in peripheral nervous function in central nervous diseases 
Routine diagnostic studies 
In physiology, there are adaptations at the alpha motor neuronal level in response to 
descending electrical inputs and activity. With increased voluntary activity seen with training, 
there is a large body of evidence that there are ‘changes of dendrite restructuring, increased 
protein synthesis, increased axonal transport of protein, enhanced neuromuscular 
transmission dynamics , and changes in electrophysiological properties (Gardiner et al., 2006). 
Under these conditions, there is “hyperpolarisation of the resting membrane potential and 
voltage threshold, increased rate of action potential development, and increased amplitude of 
the afterhyperpolarisation”. These changes with endurance training appeared different to the 
acute effect of exercise. Acute exercise appears to increase motor neuronal excitability via 
monoaminergic systems, but regular training appears to have the opposite effect.  
The clinical finding of peripheral muscle wasting contralateral to parietal lobe lesions has been 
known for some time. Peripheral nerve perturbations as a result of disorders that have a 
supposedly ‘pure’ action on the CNS and the upper motor neuron, have been extensively 
studied, but mostly in literature of the 1970s to 80s. There are multiple accounts of 
denervation changes recorded in paretic muscles in patients that have suffered a stroke or 
cerebral contusion. Their findings are listed in the following Table 1.4. 
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Table 1.4. Peripheral nerve studies in nervous diseases 
Author - year Disease (number of patients) Findings 
(Johnson et al., 1975) Stroke (20) Needle EMG - spontaneous activity 7-10 
days after stroke, firstly in antigravity 
muscles, then their antagonists, and 
finally distal muscles 
(Spaans and Wilts, 
1982) 
Cerebral contusions (10) 
  
Needle EMG – spontaneous activity in 2-
3 weeks, diminishing in 6 months 
(Benecke et al., 1983) Stroke (101) Needle EMG – spontaneous activity 2-3 
weeks after stroke, distal more than 
proximal, reduced with the 
development of spasticity and increased 
voluntary reinnervation 
(Dietz et al., 1986) Stroke (4) Needle EMG and biopsy – biopsy 
showed target changes in type 1 fibres 
(Brown and Snow, 
1990) 
Stroke (20) Needle EMG – fibrillations in distal and 
intermediate muscles 
(Dattola et al., 1993) Stroke (?) Needle EMG/SFEMG of paretic 
gastrocnemius m. – fibrillation in more 
recent disease, and long duration MUPs 
in longer disease; muscle biopsy - type 1 
fibre increase because of reinnervation, 
and type 2 fibre reduced with atrophy 
(Kirshblum et al., 2001) Tetraplegia from cervical injury 
(25) 
NCS – diminished motor/sensory 
amplitudes and  motor conduction 
velocity in the legs; EMG – spontaneous 
activity recorded in at least 92% 
(Ginsberg and Martin, 
2002) 
Rat study Transneuronal apoptosis of the target 
neuron induced within the CNS with 
transection 
 EMG = electromyography, SFEMG = single fibre EMG, MUPs = motor unit potentials. 
The above studies suggest that there is an effect of the central lesion on the lower motor 
neuron. The effect was most often construed as denervation because of the presence of 
spontaneous activity, and appeared to be maximal in the first few weeks after the central 
injury. It is noted that the period of its first appearance coincided with the timeframe for the 
appearance of spontaneous activity after an injury to nerve, with the earliest positive sharp 
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waves observed at 7 days and fibrillations at 10 days (Dmitru D. et al., 2002). The muscles that 
were affected were more distal and the pattern did not conform to a peripheral nerve or 
plexus distribution. This was important especially in those with traumatic brain damage, who 
may have suffered trauma to the PNS. Authors mostly concluded that there was a dying-back 
phenomenon, either from a lack of innervation firing to the upper motor neuron, or from a 
trans-synaptic alpha motor neuron degeneration.  
Studies of peripheral axonal excitability in central nervous system disease 
The remote effects of upper motor neuron lesions have recently been studied using the 
excitability methods that are described in this thesis (Ng et al., 2008). This method could prove 
useful to assess the long-term consequences of a central lesion if the trans-synaptic patterns 
alluded to above, had an effect on the excitability of peripheral motor and possibly even 
sensory axons. There were several clues to the possibility of altered excitability changes in this 
setting. Firstly, the excitability of motor neurons has been observed to increase following 
spinal cord isolation experiments in rats (Button et al., 2008). In this experiment, the 
differential effects of isolation involving descending, ascending and afferent inputs, and that of 
descending inputs alone were studied. Lower motor neurons in the rat sciatic nerve exhibited 
lower rheobase, higher spike afterhyperpolarisation amplitudes and input resistances 
compared to controls. The frequency-current relationships were consistent with persistent 
inward current (PIC) activation. The findings were not different between the different types of 
spinal cord isolation/transection, leading the investigators to conclude that the effect was 
because of descending input interruption. These PIC currents and their relative contributions 
from TTX-sensitive persistent Na
+ 
currents (Na
+ 
PIC), and nimodipine-sensitive Ca
2+ 
currents 
(Ca
2+ 
PIC) have been assessed in other studies of spinal cord injury (Li et al., 2004). The 
mechanism for their behaviour probably lies with neuromodulation via intracellular second 
messenger systems, under the control of monoaminergic agents such as serotonin and 
noradrenaline (Heckmann et al., 2005, Heckman et al., 2009). In the acute stages of spinal cord 
injury (SCI) when there is spinal shock, PICs and plateau potentials disappear in response to 
interruption of descending monoaminergic pathways. With time, these PIC changes would 
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again become elicitable, and could return, triggering plateau potentials and self-sustained 
motor neuron discharges that contribute to increased resting activity and spasticity (Gorassini 
et al., 2004, Nickolls et al., 2004, Hornby et al., 2006). It has been shown in rats that the 
mechanism underlying this return and increased resting activity is the result of post-
transcriptional editing with the appearance of 5-HT2C receptor isoforms that do not require 
the presence of 5-HT (Murray et al., 2010). 
 
At the time of the works in this thesis, there were two other nerve excitability studies utilising 
the automated Trond protocol that were being conducted, looking at changes in peripheral 
nerve excitability at the wrist, studying a central lesion using computerised threshold tracking 
methods (see Chapter 3). These were in stroke and chronic spinal cord injury. In the first, 
Jankelowitz et al. undertook motor and sensory studies on peripheral nerves on the paretic 
and unaffected sides of 11 stroke victims, with lesions sustained 1-10 years prior in cortical, 
subcortical and pontine locations (Jankelowitz et al., 2007). The findings were those of reduced 
inward rectification (Ih) in the motor axons on the paretic side, and there was possibly 
increased Ih in the unaffected side on modelling. There were no changes noted in sensory 
axons. This led the authors to conclude that there may be alterations in the activity of HCN 
isoforms, of which there are four (see before), that reflected or adapted to the degree of 
activity in the motor neuronal pool that was present in that limb. More recent observations of 
the acute effects of supratentorial stroke suggest a very different profile in the acute period 
with reduced superexcitability, increased RRP and a mild reduction in threshold alteration to 
both depolarising and hyperpolarising conditioning current (‘fanning-in’) of TE. These changes 
were noted in studies within the first 10 days of the insult (Bae, 2012). This led the author in 
that study to conclude that there is membrane depolarisation and decreased internodal 
resistance in the early stages.  
The second study was of subacute and chronic SCI (Lin et al., 2007). This study included 
microneurographic techniques that demonstrated a reduced ability to stimulate motor axons 
in the lower limbs. In 15 of 24 subjects, studies of axonal excitability demonstrated an 
increased threshold to stimulation. CMAPs and SDTC were reduced. The excitability changes 
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were more prominent the more severe the SCI, and it is interesting to note that some changes 
were found in the upper limbs in patients who were paraplegic. The changes were complex 
and did not easily invoke any unitary process such as membrane depolarisation. Perhaps, the 
changes would have been clearer in a longitudinal study following acute SCI. After all, there are 
changes that occur both in health and disease with spinal cord plasticity as a result of changes 
in  activity (Wolpaw and Tennissen, 2001), and changes in activity levels could be different as 
the lesion becomes older. Such a study was conducted subsequent to the studies in this thesis 
(Boland et al., 2009). Here the authors followed 11 patients with traumatic SCI within 2 weeks 
of injury up until discharge at least 2 months later, and demonstrated depolarisation-type 
features in motor nerves that were more pronounced again in the lower than the upper limbs. 
There were ‘fanned-in’ appearances in TE, reduced superexcitability, as well as increased 
refractoriness in the common peroneal nerve. These changes appeared early on in the phase 
of spinal shock and appeared to resolve thereafter and into the development of spasticity.  
There are clearly reasons why differences may exist in these two first studies involving stroke 
and acute SCI. At a clinical level, spasticity seems to be more pronounced in the latter. The 
physiological effects of spinal cord interruption differ from those of stroke by reduced 
recurrent inhibition (normal or increased in stroke), and decreased presynaptic inhibition of Ia 
terminals (normal in stroke) (Burke and Pierrot-Deseilligny, 2005). However, fusimotor 
function drive does not appear altered in chronic SCI in a recent study published since the 
works of this thesis (Macefield, 2013).  
The reverse: Changes in central nervous function in peripheral nervous diseases 
 
Adaptive responses also occur in the CNS when the PNS is injured. These were seen in chronic 
constriction injury models of neuropathic pain, where Nav1.3 has been shown to be 
upregulated in first order/DRG, second order/dorsal horn cells, and third order 
neurons/ventral posterolateral nucleus of the thalamus, demonstrating a possible 
hyperexcitability that could be important in the genesis of neuropathic pain (Dib-Hajj et al., 
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1999, Hains et al., 2004, Zhao et al., 2006). Such changes in the DRG were not seen with 
central transection of the first order sensory neuron (Black et al., 1999). 
Central nervous system disease: Multiple sclerosis 
Multiple sclerosis (MS), also known as disseminated sclerosis, is caused by an immune attack 
against antigens which have traditionally been felt to be limited to the brain and spinal cord. 
Although the primary damage is to oligodendrocytes, axons and neurons are also damaged. 
The world prevalence of MS is estimated to be 1.25 million people (Dean, 1994). The incidence 
of MS appears to be increasing around the world. In the United States for example, the 
incidence was 3.2 per 100,000 cases per year in 1990s, and 4.2 in 2007. There have been 
increases noted in Scotland, Finland, Norway, Lower Saxony, Sardinia, Italy, Sicily, and the 
French West Indies (Kurtzke, 1991). There is a well described increase in prevalence rates with 
distance from the equator (Kurtzke, 1977). Here in Australia, the crude prevalence of MS in 
New South Wales on National Census Day in 1981 was 37.2/100,000 and the age-standardised 
prevalence 36.6/100,000. The female:male ratio was 2.3:1. There were no Aborigines or Torres 
Strait Islanders with MS in that census. The effect of latitude was again seen and recorded to 
be about seven times more frequent in Tasmania than in far north Queensland, but no genetic 
differences were found. It is uncertain if an increase in prevalence noted was really an increase 
in incidence (McLeod et al., 1994).  
The latitudinal differences are assumed to be due to a complex interplay of genes, the 
environment including vitamin D state, and UV light exposure; a possible viral/infectious 
agent(s) has also  been proposed (Acheson, 1977). Many susceptibility genes have been 
identified in genome-wide studies (Hafler et al., 2007). The pathogenesis of MS appears to be 
defective immune self-tolerance, which along with viral promoter(s), results in a T-helper cell 
mediated attack on myelin. The role of genes appears to be in little doubt, with concordance 
rates in monozygotic twins of 31% being the highest, down to a sibling risk of 3.5% (Sadovnick 
et al., 1993) . However, no single Mendelian gene appears to be responsible, with a limited 
number of genes affecting susceptibility.  
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The clinical symptoms of MS vary from mild to aggressive, with the course giving rise to 
subtypes according to relapses or progression. There are relapsing remitting, progressive 
relapsing, secondary progressive and primary progressive forms. Most patients start off as 
relapsing remitting and a great majority then enter a secondary progressive phase with time. 
There are multiple symptoms including fatigue and disturbed sensory, motor, optic nerve, 
brainstem and cerebellar features. An exacerbation/relapse can last hours to weeks (at least a 
day by definition) but is typically 2-6 weeks in duration, and can then remit, sometimes 
completely. An estimated 40% of exacerbations may cause long-lasting deficits but 20% will 
improve (Lublin et al., 2003). Uhthoff’s phenomemon describes the transient worsening of 
symptoms during warm periods, which do not represent an exacerbation, and is seen in some 
80% of patients (Nelson et al., 1988, Guthrie and Nelson, 1995).  
MS plaques have a predilection for certain areas in the CNS, affecting both gray and white 
matter. Periventricular, periaqueductal and optic nerves are common sites, and cord lesions 
are often subpial. ‘Normal appearing white matter’ indicates areas on MR that are not 
apparently involved but magnetic resonance spectroscopy may be abnormal and histologically, 
axonal loss can be seen near plaques. A plaque is usually a well demarcated area of myelin 
loss, inflammatory cells and gliosis but with a relative preservation of neurons and axons. 
There is prominent demyelination and usually a degree of axonal transection of loss in most 
plaques but sometimes the latter can be quite marked (Trapp et al., 1998). Astrocytes become 
swollen, incorporating myelin breakdown products, and the lesion in several months becomes 
fibrillary, scar forming and gliotic. The blood-brain barrier appears breached, and although 
there may be a loss of tight junctions as well, there is likely a chemoattraction near capillary 
venules for T-helper cells. The pathology of MS lesions and their pathogenesis are complex, 
and beyond the scope of this thesis. However, the role of ion channels and how they are 
disordered may be important to understanding dysfunction and how axonal degeneration 
eventuates in this disease (see earlier).  
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Excitability studies on peripheral nerves in MS 
There are many reports in the literature, both as case series and anecdotal, of peripheral nerve 
abnormalities in MS. Some, mainly case series, appear to describe a hitherto unrecognised and 
rather mild peripheral involvement in a relatively common neuroinflammatory disorder by 
studying unselected patients with MS, but others describe a clearer involvement of the 
periphery with marked demyelination similar to chronic inflammatory demyelinating 
neuropathy (CIDP). The latter condition appears to be a more common association than acute 
inflammatory demyelination of Guillain-Barré syndrome (GBS) (Uncini et al., 1988, Panegyres 
and Mastaglia, 1989). The studies that include excitability methods are discussed later; those 
that do not are summarised below: 
Case reports or case series: 
(Hasson et al., 1958): Autopsy with peripheral nerve examination (multiple nerves 
examined including median, ulnar, femoral, posterior tibial, plexus) in 20 patients. Six 
showed severe diffuse peripheral demyelination and 6 slight to moderate 
demyelination. Nerve fibres were affected over long distances and did not have a 
plaque-like appearance, consisting of fascicular demyelination. These findings occurred 
almost exclusively in emaciated patients, leading the authors to attribute the findings 
to nutritional or pressure palsies.   
(Miglietta and Lowenthal, 1961): Only 3 of 54 cases of MS had peripheral involvement.  
(Pollock et al., 1977): Sural nerve biopsies from 10 patients. Internodes showed a 
reduction of myelin thickness by 50% and a reduction in lamellae, without a reduction 
in myelin fibre density.  
(Schoene et al., 1977): Four cases at autopsy, with onion bulbs seen in the PNS. Two 
cases had similar onion bulbs noted within the CNS.  
(Weir et al., 1979): SFEMG in 15 patients with MS, two of whom had no other evidence 
of neuropathy. Eleven with abnormalities.  
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(Thomas et al., 1987): Six with CIDP assessed with CT/MR and found to have relapsing 
multifocal demyelination.  
(Mendell et al., 1987): MR examination of 16 cases of CIDP showed demyelination in 6, 
of whom 3 were diagnosed as MS clinically and on laboratory findings.  
(Zee et al., 1991): Seventeen (11%) of patients with either a radiculopathy (13) or 
peripheral neuropathy (4).  
(Sarova-Pinhas et al., 1995): Twenty two mildly disabled had electrophysiologic 
abnormalities in 33 (15%) of 244 nerves examined in 10 (46%) of patients, consistent 
with a sensorimotor neuropathy, the severity of which did not correlate with clinical 
features.  
(Pogorzelski et al., 2004): Seventy MS patients with at least one nerve affected on 
neurophysiological studies suggesting a mixed demyelinating and axonal picture. No 
correlation with demographic and MS features.  
(Pineda et al., 2007): Six of 18 CIDP found to have central demyelination with MR and 
electrophysiological techniques. 
There are reports of isolated or a few cases. These do raise the possibility of a chance 
occurrence of the two conditions, given that the conditions are not in themselves rare:  
(Forrester and Lascelles, 1979): Two cases of CIDP and MS. 
(Lassmann et al., 1981): One case of CIDP and MS.  
(Rosenberg and Bourdette, 1983): Hypertrophic neuropathy in a case of MS at 
autopsy. 
(Ro et al., 1983): One case with hypertrophic demyelinating neuropathy on sural nerve 
biopsy.  
(Best, 1985): Acute polyradiculoneuritis in one case with autopsy evidence of MS. 
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(Tachi et al., 1985): 12 year old with, optic neuritis and transverse myelitis, with 
proven sural demyelination. 
(Rubin et al., 1987): Two cases of MS studied with clinical, electrophysiological and 
sural nerve biopsy showing demyelinating neuropathy.  
(Drake, 1987): One patient with MS and nonspecific sural neuropathic findings.  
(Saito et al., 1990): One case with sural nerve showing myelinated and unmyelinated 
fibre loss, as well as functional and electrophysiological tests of autonomic 
dysfunction.  
(Arias et al., 1992): One case with hypertrophic demyelination on sural biopsy.  
(Watanabe et al., 1993): One case of CIDP and MS. 
(Di Trapani et al., 1996): Study of 2 cases of MS with peripheral demyelinating disease 
on nerve biopsy. 
(Drulovic et al., 1998): Study of 2 cases of MS with tomaculous neuropathy on sural 
nerve biopsy.  
(Liguori et al., 1999): Two cases with CIDP and MS 
(Quan et al., 2005): Two cases of MS and CIDP with massive spinal and cranial nerve 
hypertrophy. 
(Falcone et al., 2006): Two cases of MS and CIDP.  
The lists above are not exhaustive. There are more cases in the literature, but they serve to 
illustrate that the co-occurrence of central and peripheral pathology in the same patient is well 
recognised. On the whole, the peripheral nerve abnormalities seen on histopathological 
examination in these various studies are those of demyelination, often with onion bulbs or 
hypertrophic nerve changes. This suggests that there may be a common immune attack on 
peripheral nerve. However, the slowing seen on electrophysiological techniques does not 
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suggest gross demyelination in most cases of MS, and one suspects there is a bias of reporting 
for cases of CIDP, especially early in the literature when a connection between CNS and PNS 
demyelination was first suggested. Nevertheless, a link is plausible as there are antigenic 
similarities in the myelin of the PNS and CNS. As mentioned earlier in this chapter, the 
structure and function of myelin in the CNS and PNS is similar despite the different cell types 
(oligodendrocytes and Schwann cells respectively). Both form compact lamellae that invest 
axons and ensure the security of conduction as previously discussed. Myelin proteins such as 
P0 and P2 are seen only in the PNS but P1 and Pr are either very similar or identical in both the 
CNS and PNS, and they could present an antigenic target (Waxman, 1993). Furthermore, MAG 
is found in both the PNS and CNS. EAE is an ideal example. Here, the experimental condition 
results from inoculation of bovine white matter and Freund’s adjuvant into the rabbit. Anterior 
spinal root examination in these animals may show recurrent demyelination and remyelination 
(Raine et al., 1971). Similar demyelination has been shown in rats and rabbits following 
inoculation with whole spinal cord or MBP (Pender, 1988). However, although EAE may 
represent an animal model of MS, no animal model has been shown to reproduce MS 
faithfully. The doctrine of primary inflammatory processes has in fact been challenged by a 
more recent report of a primary apoptotic process of oligodendroglia in early lesions similar to 
the Luchinetti type IV lesion (Barnett and Prineas, 2004). 
How can structural change brought about by demyelination affect the ability of axons to 
generate or conduct an impulse? Early experiments have shown that a reduction of myelin 
thickness by about 75% is required before there is a significant reduction in conduction 
velocity (Koles and Rasminsky, 1972). Similarly, internodal distances have to be reduced by 
more than 50% to achieve a similar result (Brill et al., 1977). However, it should be noted that 
demyelination in the absence of conduction block or axonal degeneration produces few if any 
symptoms, and this may be the explanation that there can be a high lesion load on MR with 
minimal or no appropriate deficit.  
In demyelination, axo-glial interactions at the paranode appear important with erosion of the 
paranodal seal in cases of peripheral demyelination.  These could interfere with the 
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conduction of action potentials by introducing a shunt under otherwise intact myelin (Hirano 
and Dembitzer, 1969). The macromolecular properties at the axo-glial junction act to seal the 
terminal myelin loops creating a high resistance pathway at the paranode that is normally 
impermeable to all but a few molecules. This effectively differentiates the milieux of the node 
and internode. An increased conductance through these “Barrett and Barrett” pathways 
occurs via demyelination with the passage of current under the normally tight myelin seals 
(Barrett and Barrett, 1982, Blight, 1985, Stephanova et al., 2005) (see previous). This would 
have a profound effect on the DAP, with its dissipation affecting supernormality (Bowe et al., 
1987). Other accompanying changes include an increase in nodal capacitance which could 
decrease conduction velocity and increase the refractory period.  
So can central changes of the DRG, be they demyelination or axonal transection, affect the 
DRG and its peripheral processes? It has been proposed that this could occur with one of the 
following mechanisms (Waxman, 1993): (i) Alteration in the resting membrane potential and 
threshold could arise as a result of firing frequency. These operant conditioning responses may 
be influenced by the level of activity, and may be the reverse geographical effect of what has 
been shown above in central neurons with peripheral constriction injury models; (ii) Alteration 
in the availability of metabolic substrates/ATPase, which in turn would lead to changes in RMP; 
(iii) An increased requirement for Na
+
 channels in the central demyelinated segments may see 
a lack of sufficient Na
+
 channels in the periphery. In demyelination, denuded axons reorganise 
and upregulate Na
+
 channel expression, and redistribute to ensure conduction is preserved, 
albeit inefficiently (Bostock and Sears, 1978). If there are fewer channels in the periphery as a 
result of deficits within the neuron as a whole, this may translate to reduced conduction 
velocity and possibly impulse propagation block. The channels elaborated as a result of this 
overall neuronal channel deficit may also have altered properties, which could affect gating 
and kinetics (Waxman, 1993).  
The above may be one way that the peripheral nerve may be affected by remote processes, 
and introduce a more indirect effect or peripheral plasticity. Nevertheless, a direct mechanism 
could appear more likely, with the observations noted of peripheral nerves in MS in the 
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literature detailed above. Several lines of evidence including immunohistochemical and 
electrophysiological studies indicate that Na
+
 channel density increases following 
demyelination. Antibodies can also alter the gating and kinetic properties of channels. If it 
could be demonstrated that there is a primary disorder of channels in the periphery using the 
techniques in this study, then it would confirm that MS may not be just a disorder of myelin, 
and that the disorder may also encompass an acquired channelopathy, as has been postulated 
by Waxman (Waxman, 2001). This would provide a rationale for channel-targeted therapy, 
from Na
+
 channel blockers (Kapoor et al., 2003, Waxman, 2006) to K
+
 channel blockers (Judge 
and Bever, 2006), as has been explored in the past in MS. However the results of such 
treatments are again, beyond the scope of this introduction. The modelling tool may also allow 
us to differentiate if morphological changes take precedence over ionic channel alterations.  
Excitability studies on peripheral nerves in MS 
There are previous reports of excitability studies on the peripheral nerves of subjects with MS, 
though these are mainly of the recovery cycle or phases of it. These studies generally involved 
unselected case series of patients with MS with little in the way of overt peripheral clinical  
Table 1.5. Comparison of peripheral excitability studies in MS prior to this thesis 
Author  Nerve   n Findings 
(Hopf and Eysholdt, 
1978) 
Median 36 Sensory: RRP prolonged, but no change in CV 
(Eisen et al., 1982) Median 40 Sensory: Seventeen (42%) – no supernormality 
(Shefner et al., 1992) Sural 14 Sensory: Reduced minimal CV (9, 64%); reduced 
supernormality  
(Antonini et al., 1995) 
(letter) 
Median  15 Sensory: RRP increased – not correlated with clinical 
features 
(Böerio et al., 2007) Ulnar 20 Motor: supernormality reduced; ARP and RRP increased 
(Misawa et al., 2008)* Median/ 
Radial 
60 Median motor and radial sensory: 3 (5%) had 
concurrent CIDP. No changes in any excitability 
parameter 
* study performed the same year as that of MS motor axons in this thesis 
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symptoms or signs. Therefore, they probably do not explore fully the vast majority of the types 
of patients contained in the anecdotal reports above, which may represent either a different 
condition or one end of a spectrum of degree of peripheral involvement in MS. As mentioned, 
MS is not uncommon and a chance association of a marked co-existing peripheral 
inflammatory disorder is possible. Their findings are summarised in the following Table 1.5. 
The consistent picture of the above studies is that there is a reduction in supernormality and 
an increased refractory period. All but Misawa et al. (Misawa et al., 2008) utilised techniques 
older than threshold tracking employed in this thesis, and the measurements are only of one 
physiological process (the recovery of excitability after discharge), and changes in the recovery 
cycle in isolation can be difficult to interpret. Misawa et al. utilised the full Trond protocol but 
did not demonstrate any significant changes in axonal excitability. It did, however, note that 
there were concurrent changes of CIDP in 5% of patients, which is more than would be 
expected from a chance association in an unselected group. 
Excitability studies in demyelinating disorders of peripheral nerve 
When a nerve becomes demyelinated, there is a dynamic reorganisation of the Na
+
 channels. 
These channels are normally concentrated at the node, and a low density population becomes 
exposed under the denuded axolemma (Ritchie and Rogart, 1977). The recovery of the action 
potential is brought about an increase in Na channel expression at these sites. Similarly in the 
EAE model of MS, Nav1.2 and Nav1.6 are upregulated. As Nav1.6 is associated with the Na
+
-Ca
2+
 
exchanger and the persistent Na
+
 current, upregulation of this isoform may be maladaptive 
(Craner et al., 2004, Waxman, 2006). There is some evidence that there is an antiganglioside 
antibody response to epitopes that mediate an inflammatory cascade that results in disruption 
in nodal Na
+
 channels in the acquired peripheral demyelinating disorders, predisposing to 
conduction block (Takigawa et al., 2000, Susuki et al., 2007). 
There are also changes in K
+
 channels that accompany demyelination. An exposure of 
paranodal fast K
+ 
channels tends to clamp the membrane potential close to the equilibrium 
potential for K
+
, Ek, and therefore this can lead to conduction block (Waxman and Ritchie, 
1993). Over time, the disorganisation of the Kv1 channels mean they co-localise with Na
+ 
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channels and disrupt the paranode (Rasband et al., 1998, Arroyo and Scherer, 2000). It is this 
disruption coupled with a reduction in nodal conductance that leads to conduction block. A K
+
 
channel redistribution to the rest of the internodal regions also increases the paranodal 
capacitance, increases the resistance and therefore, can slow conduction velocity (Boyle et al., 
2001). This has led to trials in 4-amoinopyridine in MS because of its ability to block K
+
 
channels (Bostock et al., 1981).  
In a study of the potential peripheral effects of MS with excitability methods, it becomes 
necessary to note the previous studies of primary peripheral de-/dys-myelinating processes. 
Their excitability changes are summarised in the following Table 1.6. This table lists the 
disorders in rough perceived order of the degree of uniformity of the demyelinating process at 
a microscopic level along the length of the nerve (Cappelen-Smith et al., 2001, Kiernan et al., 
2002, Kuwabara et al., 2002, Kuwabara et al., 2003, Nodera et al., 2004, Sung et al., 2004). 
Towards the left of the table are the inherited forms which are generally uniform in their 
morphometric effect on nerves, even though there is some inhomogeneity in CMTX1 
neuropathy and marked inhomogeneity in HNPP. Almost all have a documented increase in 
threshold and rheobase, concordant with the electrophysiological observation that nerves are 
often difficult to stimulate in these conditions. Threshold electrotonus generally reveals a 
‘fanning-out’ of the responses indicating a greater threshold change and less accommodation 
to depolarising and hyperpolarising conditioning currents. These have been observed by Sung 
to be most marked in CMT1A, moderate in CIDP and least prominent in AIDP/GBS, leading the 
authors to conclude that the findings were related to the uniformity of demyelinating changes 
(Sung et al., 2004). There are inconsistent reductions in the RRP and superexcitability through 
the studies. Attempts to interpret the previous findings  generally invoke morphological 
changes of a reduction in myelin or an increased fast K
+
 current, perhaps from paranodal 
axonal exposure. It would be instructive to apply the Trond protocol to allow multiple 
measures to be studied and possibly modelled in the peripheral nerves of MS to observe if 
similar changes of demyelination or other processes are present. 
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Table 1.6.  Excitability changes in peripheral demyelinating disorders  
   CMT1A  CMTX  HNPP  CIDP1  CIDP2  AIDP  AMAN  MMNCB 
Normalised SR curve  reduced slope N  ↓ slope*  ↓ slope  ↓ slope*      N for most 
Rheobase   ↑  ↑  N  ↑  ↑      ↑ 
SDTC   N  N  N  ↓  N  N  N  N 
TE   fan out  fan out  fan out*  N  fan out**  N  N  fan out 
IV     complex  greater Ih*  N  N      ↓ resting IV slope 
RRP   ↓  ↓  N  N  ↓  N  ↑  ↓ 
Superexcitability  N  ↓  N  ↓  N  N  N  ↑ 
Subexcitability  N  N  N  ↓  ↓  N  N  N 
Interpretation  ↓myelin  ↑ fast K
+
  morphol  morphol  esp in severe  N  distal CB  focal depol;  
                 distal hyperpol 
* not identified as significant; * * seen in the diffuse subgroup; N = normal or  not significant; CB = conduction block; depol = depolarisation; hyperpol = hyperpolarisation; morphol = morphological change 
CMT1A – Nodera (2004); CMTX – Liang (accepted Nov2013, Clin Neurophysiol); CIDP1 – Cappelen-Smith (2001); CIDP2 – Sung (2004): AIDP – Kuwabara (2002); AMAN – Kuwabara (2003); MMNCB – Kiernan  
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The studies in this thesis aim to discover some important features of peripheral axonal 
excitability testing, as they relate to interpretation of local changes as well as remote effects of 
CNS disease. These are:
1. Is excitability testing useful for determining pathophysiology?  
There are many previous peripheral neuropathic conditions that have been assessed with the 
excitability techniques proposed for the studies in this thesis. This thesis examines three 
hitherto unstudied conditions (end-stage liver disease, HIV infection, and mitochondrial 
disease) to determine if the priori hypotheses regarding the pathophysiology of their 
neuropathy can be supported. These hypotheses can be made because previous studies have 
inferred various pathophysiological processes such as membrane potential alterations (for 
example, from ischaemia or hyperkalaemia) or specific channelopathies.  
2. Is excitability testing a sensitive measure of neuropathy, and is it correlated to clinical 
signs and standard nerve conduction abnormalities?  
Having determined if there are changes in excitability in the above cohorts, correlations will be 
sought with standard indicators of a neuropathy (i.e., clinical signs and standard nerve 
conduction studies). This will attempt to address a question of its potential utility in clinical 
practice.  
3. Are there changes in excitability of the peripheral nerve axons in diseases primarily of 
the central nervous system?  
Some literature has already been presented for stroke, and reports have been published after 
the studies in this thesis for spinal cord injury. To look at this, a condition widely thought to be 
solely a central disorder, MS, is examined.  However, rarely, as noted in the previous chapter, 
peripheral neuropathy can occur in MS and central nervous system demyelination has been 
seen in CIDP. In addition, abnormalities of peripheral nerve excitability have been documented 
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in MS, but mostly only in recovery cycles of sensory axons, and before the methods outlined in 
this thesis.  
Therefore, the aims of this section are two-fold. Firstly, to determine if the changes in motor 
and sensory axons in MS are due to a peripheral process, and if so, to work out what process is 
suggested. Secondly, to determine if the changes peripherally arise from central nervous 
system effects, i.e., ‘adaptive’ responses, as have been documented in other conditions as well 
as physiological situations such as exercise training.  If required, modelling studies will be 
employed in an attempt to differentiate the two potential processes.
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General Methodology 
In this section, the general methodology that is common to the studies in this thesis is 
described. More specific information on study design and equipment is provided in the 
methodology sections in Chapter 4 (see later). Except in the central disorder MS, patients 
usually underwent an assessment that comprised the following components, and tests were 
performed whenever possible on the same side for all techniques. The techniques of nerve 
conduction, autonomic function assessment and thermal threshold estimation outlined below 
conform to International Federation of Clinical Neurophysiology published guidelines for 
testing (Deuschl, 2000). 
Medical history 
A standard medical history was taken with questions regarding motor or sensory deficits (e.g. 
numbness and weakness) and positive symptoms (e.g. fasciculation, cramp, and 
paraesthesiae). Consideration was given to the topography of sensorimotor symptoms and 
signs. Attention was also paid not only to lower limb symptoms which were predominant in a 
length-dependent neuropathy, but to the symptoms and signs present in the median 
distribution of the hand, the common site of testing for excitability studies. This was to permit 
a correlation of the clinical features with excitability parameters derived from that nerve. The 
clinical information recorded was also specific for that disorder, e.g. Child-Turcot-Pugh or 
MELD (model of end-stage liver disease) scores, neuropathy type, length of the infection in HIV 
neuropathy, or genetic typing in mitochondrial disease.  
Clinical examination  
This documented any clinical evidence for a peripheral neuropathy, but a scoring system 
utilising the Total Neuropathy Score (TNS) (Cornblath et al., 1999), modified to omit 
vibrameter recordings was also collected (known as the ‘modified’ TNS – see later).  
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Standard nerve conduction 
Standard nerve conduction parameters were collected according to IFCN guidelines (Kimura). 
Studies were performed on Nicolet Viking or Medelec Synergy devices. These studies included: 
median, ulnar, radial (antidromic), sural and superficial peroneal sensory studies; and median, 
ulnar, peroneal, and tibial motor studies. Motor conduction velocity was recorded for median 
and peroneal nerves, and minimal F-wave latencies recorded for ulnar and tibial motor studies. 
H-reflexes were also recorded in some studies from median nerve stimulation at the wrist, 
using averaged responses recorded during a voluntary contraction (Burke 1989). Where 
necessary, a correction factor was applied for temperature compensation. Comparisons were 
made with laboratory-derived mean ±2.5 SD control limits. Patients were deemed to have a 
neuropathy if both the sural and superficial peroneal responses were below normal limits for 
age (mean±2.5SD). 
Autonomic function tests 
These were limited by their nature to the EMG laboratory equipment and software. They were 
only performed in the studies in Chapter 4A, B and D on patients with end-stage liver disease 
and mitochondrial disease. 
Heart rate  (HR) variability. Assessment was performed on Nicolet Viking MMP software 
(Viasys, Madison, WI, USA). 
Inspiratory – expiratory ratio. This test measured the mean difference between the longest 
and the shortest RR interval in response to deep breathing, known as the expiration-
inspiration (‘E-I’) value. The procedure followed was to establish baseline and then record the 
greatest variation at 6 breaths / minute (in - out) of near maximal tidal volume breathing. The 
mean of 5 Expiratory - Inspiratory (E-I) RR intervals in milliseconds was calculated. The highest 
and lowest HR during each phase of inspiration/expiration appears as peaks and troughs in the 
real time graph of HR against time. The calculation of interval can be derived as follows: 
Mean highest HR peaks = (x1+x2+x3+x4+x5) /5 
Mean lowest HR troughs = (y1+y2+y3+y4+y5) /5 
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RR = [60/mean lowest HR – 60/mean highest HR] x 1000 in msecs.  
This substitute mathematical algorithm is permissible because in this case, the difference of 
the means is the same as the mean of the differences. 
30:15 ratio. The procedure followed was to initially establish a stable baseline heart rate with 
the patient sitting. Then, the patients was asked to stand, and the greatest increase at ~15th 
beat (exercise reflex), and the greatest decrease at ~30th beat (baroreflex) was recorded. The 
30:15 ratio is that of the longest to the shortest RR interval. 
The Valsalva manoeuvre as the ‘VR’ ratio. After establishing the baseline HR, the subject 
was asked to blow into a tube with a small leak, maintaining 40 mmHg for 15 secs on a 
sphygmomanometer cuff. The VR Ratio is the ratio of the longest RR interval (after the end of 
the strain period) to the shortest (towards end or after strain period). It should be noted, in 
this method of testing, blood pressure monitoring was not undertaken. If the HR response is 
not normal, further tests are required to establish that the change in BP was sufficient to 
trigger a HR variation before the test can be deemed abnormal.  
The normal values were those published in 120 healthy subjects (Ziegler et al., 1992). 
Table 3.1. Normal values for HR variability  
Age (yrs) 20 25 30 35 40 45 50 55 60 65 
E-I (ms) 136 127 119 112 105 98 92 86 81 76 
30:15 1.15 1.14 1.12 1.11 1.1 1.09 1.08 1.07 1.07 1.06 
VR 1.22 1.22 1.21 1.2 1.19 1.19 1.18 1.17 1.17 1.16 
 
Sympathetic skin responses were obtained in response to a random noxious electrical 
stimulus to the median nerve at the wrist, and were measured in the hand and foot. 
Responses were regarded as abnormal if they were absent. Absent responses were validated 
subsequently with other stimuli, such as auditory stimuli and sudden inspiratory gasp.  
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Thermal threshold studies 
These studies were only performed in the studies of Chapter 4A and B, in patients with end-
stage liver disease. Small fibre function was assessed by the Marstock method of limits on 
custom-built commercial devices (Somedic systems v2.2). Two standardised sites were 
selected for assessment: the thenar eminence of the right hand and the dorsal aspect of the 
right foot. A 2.5 × 2.5 cm thermode which acts on the Peltier principle was used to provide 
warm and cool stimuli. There were 5 stimuli for each limit. A skin adaptation temperature of 
32
o
C was applied for 5 mins to each site before warm and cool thresholds were assessed. This 
temperature also served as a baseline between each stimulus. The stimulator temperature 
range was 0 − 50
o
C and the temperature ramp speed was 1
o
C/s. The return rate after stimulus 
detection was also 1
o
C/s and the temperature remained at 32
o
C for 4 − 6 s between stimuli, 
with the length being varied in order to minimise anticipation by the subject. Standardised 
instructions were read to the subject in order to reduce error and bias due to the operator. For 
each site, the warm percept was measured five times and the cool percept for five times, in 
that order. The results are averaged for each individual. 
Laboratory blood studies  
Here, various blood parameters were analysed to correlate with neurophysiological findings 
including nerve excitability parameters. In different studies, these could include serum 
ammonia in end-stage liver disease, and CD4 counts in HIV, for example. The presence of 
impaired glucose tolerance, a possible confounder, was sought in the patients with 
mitochondrial disorders.  
Patients with MS also had the following parameters documented:  
Disease duration 
Kurtzke expanded disability status scale (EDSS) disability scales (Kurtzke, 1983) 
MR brain and cervical spine 
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Modified Total Neuropathy Score (mTNS) 
The modified total neuropathy score is an adaptation of a validated tool, the ‘total neuropathy 
score’ (Cornblath et al., 1999). Derived from clinical and neurophysiological observations, it is 
composed of the following with the omission of the vibrameter readings, used by Cornblath et 
al. Consequently, the maximum score is adapted from 40 to 36 (see Table 3.2).  
Table 3.2. Modified Total Neuropathy Score 
Score 
Parameter 
0 1 2 3 4 
Sensory symptoms None 
Limited to the 
fingers or toes 
Extends to the 
ankle or wrist 
Extends to knee 
or elbow 
Above 
knees/elbows or 
functionally 
disabling 
Motor symptoms None Slight difficulty 
Moderate 
difficulty 
Require help/ 
assistance 
Paralysis 
Number of 
autonomic 
symptoms 
0 1 2 3 4 or 5 
Pin sensibility Normal 
Reduced in 
fingers/toes 
Reduced up to 
wrist/ankle 
Reduced up to 
elbow/knee 
Reduced to above 
elbow/knee 
Vibration sensibility Normal 
Reduced in 
fingers/toes 
Reduced up to 
wrist/ankle 
Reduced up to 
elbow/knee 
Reduced to above 
elbow/knee 
Strength Normal Mild weakness 
Moderate 
weakness 
Severe 
weakness 
Paralysis 
Tendon reflexes Normal 
Ankle reflex 
reduced 
Ankle reflex 
absent 
Ankle reflex 
absent, others 
reduced 
All reflexes absent 
Sural amplitude 
Normal/ 
reduced to <5% LLN 
76 to 95% of LLN 
51 to 75% of 
LLN 
26 to 50% of LLN 0 to 25% of LLN 
Peroneal motor 
amplitude 
Normal/ 
reduced to <5% LLN 
76 to 95% of LLN 
51 to 75% of 
LLN 
26 to 50% of LLN 0 to 25% of LLN 
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Nerve excitability studies 
Subjects 
Control subjects were recruited for the collection of nerve excitability parameters, and other 
studies relied on published or available laboratory control data. These were from healthy 
volunteers that had been screened for common disorders that are known to be neuropathic,  
such as diabetes mellitus. A full history was also taken in case there were any other relevant 
factors. Patients with confounding conditions were excluded. For example, subjects taking Na
+
 
channel acting drugs such as phenytoin, carbamazepine, valproate, lamotrigine or mexiletine 
were excluded. Subjects were also screened with standard NCS to look for carpal tunnel 
lesion(s). These exclusion criteria were also applied to the selection of patients, but impaired 
glucose tolerance occurs in mitochondrial disease and in this instance, such patients were not 
excluded from the mitochondrial cohort. Subset analyses were undertaken to ascertain if 
patients with impaired glucose tolerance were different from the rest of the cohort in any 
respects.  
 
Equipment 
The following equipment was used in the studies in this thesis: 
Hardware: 
Medelec Synergy EMG system (Oxford Instruments, United Kingdom), or 
Nicolet Viking EMG system (Madison, WI, USA) 
Digitimer DS5 linear constant-current bipolar stimulator (©Welwyn Garden City, Herts, 
UK) 
PC/ laptop 
Grass amplifier (Natus, Warwick, RI, USA) 
Humbug 50/60Hz eliminator (Quest Scientific; North Vancouver, BC, Canada)  
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National Instruments 16-bit data acquisition Analogue to Digital system (NI-USB 6251, 
Austin, TX, USA) 
Peripherals including cables and disposable electrodes (Cleartrace, Conmed Corp, 
Utica, NY, USA) 
 
Software: 
Nerve excitability software QTracS TrondCM, TrondN and TrondNF drivers (© 
Professor H Bostock, Institute of Neurology, University College London); QTracP under 
the same licence for analysis 
 
Nerve excitability techniques – threshold tracking and experimental 
sequence 
Nerve excitability studies were performed using a previously described automated technique 
(Kiernan et al., 2000, Kiernan et al., 2001). With this technique, motor studies can be 
completed within 10 mins for motor and 20 mins for sensory studies where there are noise-
free recordings (Fig. 3.1). For median and deep peroneal nerve motor studies, measurements 
were taken from surface electrodes over abductor pollicis brevis (APB) and tibialis anterior (TA) 
respectively. Non-polarizable circular gel disc electrodes (3M, Rochester, MN) were used for 
cathodal placement over the median nerve at the wrist and the common peroneal nerve at the 
fibular neck. The anode was placed at a point 14 cm proximal to the cathode overlying the 
radius for the upper limb and over the patella for lower limb studies. For median sensory 
studies, ring electrodes were placed around the index finger and antidromic responses were 
recorded to stimulation at the wrist, as for motor studies. Skin temperature close to the 
stimulation site was maintained at a minimum of 32
o
Celsius. The following excitability 
parameters were collected as part of the recording paradigm. 
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Stimulus- response curve  
A stimulus-response curve was constructed from stimuli that increased in small increments to 
supramaximal intensity using pulses of 0.2 and 1 ms in duration for motor studies, and 0.1 and 
0.5 ms for sensory studies. The interstimulus interval was 0.8 s. This permitted the assignment 
of a target CMAP that was 40% of the peak and the current required to produce this amplitude 
was the  threshold for tracking purposes. Using the changes in stimulus intensity that define 
the SR curve, threshold tracking uses these incremental steps to deliver the appropriate 
amount of stimulus intensity step change needed to elicit the next desired response size (Fig. 
3.2).   
Figure 3.1. Time course of the recording of multiple measures 
 
Stimulus-response relationships are given in (A) for 0.2-ms duration (thick line) and 1-ms duration (thin 
line) stimuli. Threshold electrotonus is shown in (B) with +40% (thin) and -40% (thick) polarising 
conditioning current. Current-threshold relationship in (C) for recordings after 200 ms of polarising 
current. Recovery cycle in (D) at latencies after the supramaximal conditioning current from 200 to 2 ms. 
Reproduced from Kiernan et al. (Kiernan et al., 2000). 
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Figure 3.2. Schematic diagram of axonal excitability testing equipment 
 
Functions within the box carried out by personal computer. The CMAP recorded in this case 
from abductor digiti minimi, is compared to a target response, and the error signal is used to 
adjust the amplitude of the test impulse delivered via an isolated voltage-current converter. 
Reproduced from Bostock et al. (Bostock et al., 1998) 
 
Strength-duration relationship 
Five different pulse widths from 0.2 to 1 ms were delivered for motor studies, and from 0.1 to 
0.5 ms were delivered for sensory studies. Charge-duration plots were derived to give 
rheobase and strength-duration time constant, τSD (the equivalent of chronaxie), as per Weiss’ 
law – see Chapter 1 (Weiss, 1901, Mogyoros et al., 1996, Burke et al., 2001).   
Threshold electrotonus 
This term refers to the threshold changes that result from the injection of subthreshold 
conditioning currents. To record threshold electrotonus, 100-ms depolarising and 
hyperpolarising conditioning currents were used. The strength of these polarising conditioning 
currents was +20% and +40% (depolarising) and -20% and -40% (hyperpolarising) of the control 
threshold.  The test stimulus required to elicit the same target response was determined at 26 
time points with a maximum of 10 ms intervals, occurring before, during and after the 
conditioning current. Each stimulus combination at these time points was test stimulus alone, 
test + depolarising conditioning current, and test + hyperpolarising conditioning current.  The 
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combination was repeated until three responses were valid, defined as within 15% of the 
target, or were alternate responses bracketing the target.  
Current- threshold (I/V) relationship 
In this portion, threshold changes were obtained from 1-ms long test impulses, that were 
delivered 200 ms into conditioning currents lasting 220 ms. Here, the conditioning currents 
were subthreshold with an intensity from +50% to -100% in 10% steps. Stronger depolarising 
conditioning currents than this paradigm would not be subthreshold. Alternating test alone 
and test + conditioning current combinations were performed until three valid threshold 
estimates were obtained as described in the previous section. Accommodation in threshold is 
present in both depolarising and hyperpolarising conditioning current due to outward and 
inward rectifiers respectively – see Chapter 1.  
Recovery cycle 
In the final stage of the protocol, to measure the recovery cycle, stimuli were delivered to 
track threshold changes at 18 different conditioning – test current intervals ranging from 2 to 
100 ms after a supramaximal conditioning stimulus. The maximal CMAP or SNAP to the 
conditioning stimulus was subtracted from the response to the conditioning-test pair to allow 
the response to the test stimulus to be defined clearly. Four valid estimates were taken before 
each time point progressed. The changes in excitability in normal controls follow a 
characteristic absolute and relative refractory period, a period of supernormality (or 
superexcitability) and then a period of subnormality (or subexcitability).  
Data analysis 
Multiple parameters were generated by the QTracP program that allowed comparison of 
patients and control groups. The calculation of the various parameters in the program is as 
follows. The longer stimulus duration was used where there was no requirement for two 
stimulus durations to calculate the parameter: 
Latency – stimulus onset to the peak of the response, averaged for the entire recording 
Stimulus intensity for a CMAP/SNAP, the amplitude of which was 50% maximal  
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τSD – as set out in Chapter 1, plotted as the x – intercept of the plot between charge amount 
and stimulus duration; the S-D curve is hyperbolic, not exponential, and strictly speaking, this 
value is the “chronaxie”, not a time constant. It is influenced by the persistent Na
+
 current and 
the passive axonal membrane properties. 
SR slope – from the normalised SR slope, the stimulus that evokes a 25% response is 
subtracted from the stimulus that evokes a 75% response, and that is divided by the stimulus 
that evokes a 50% response 
Resting I/V slope – slope derived between the -10% and +10% conditioning current points in 
the current – voltage relationship; minimal I/V slope – slope from fitting a straight line 
through 3 adjacent points; hyperpolarising I/V slope – slope from fitting a straight line 
between adjacent points to the -90% conditioning current 
Relative refractory period – time from conditioning current to the test current that first 
intercepts the x – axis in the recovery cycle, as defined by interpolation of the points above 
and below the x – axis  
Superexcitability (%change) – mean of 3 adjacent points straddling the minimum in 
conditioning – test latencies of 5-15 ms 
Subexcitability (%change) – mean of 3 adjacent points straddling the maximum in 
conditioning – test latencies >15 ms 
Threshold electrotonus – e.g. TEd (40-60ms) is mean threshold reduction between the 
specified latencies 
TEd (undershoot) and TEh (overshoot) – peak threshold increase or decrease 
respectively, for 20 ms following termination of the conditioning current 
S2 accommodation – difference between the peak and plateau values in depolarising TE 
Accommodation half-time – time from start of depolarising current to the halfway point 
between the peak and plateau 
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Additional studies 
A computer program, MEMFIT, was employed using a model of the human motor axon 
(Bostock, 2006). The development and refinement of the model was discussed in Chapter 1. 
This modelling was applied to studies in Chapter 4C, F and G in HIV neuropathy and MS.  
The ischaemic protocol used in Chapter 4E is described in the methodology section of that 
chapter.
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Chapter 4A  
Ischaemic depolarisation of peripheral nerves in end-stage liver 
disease 
 
(Ng et al., 2007) 
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Chapter 4B  
Reversibility of end-stage liver neuropathy 
 
         (Ng et al., 2013) 
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Table. Summary of some clinical and standard neurophysiological measures  
pre- and post- transplant (pre/post) 
No.  Etiology Age NCS  AFT QST    mTNS 
1 Polycystic 39 n/n  n/n n/n    0/1 
2 Secondary BC 70 abn/n  abn/n abn/abn   4/3 
3 PSC  30 n/n  n/n abn/abn   3/1  
4 PBC  51 n/n  n/n abn/abn   0/0 
5 Alcohol  61 n/n  ?/n abn/abn   2/1 
6 Alcohol/HCV 50 abn/abn abn/n abn/n     0/- 
 
PBC = primary biliary cirrhosis, PSC = primary sclerosing cholangitis, HCV = chronic hepatitis C 
virus infection, NCS = nerve conduction studies, AFT = autonomic function tests, QST = 
quantitative sensory thermal threshold testing, mTNS = modified total neuropathy score, n = 
normal, abn = abnormal 
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Chapter 4C  
Excitability characteristics of viral and nucleoside neuropathy in 
HIV positive subjects 
 
(Ng et al., 2011) 
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Chapter 4D  
Membrane potential of peripheral nerve axons is normal in 
mitochondrial disease  
(Ng et al., 2010) 
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Chapter 4E  
Axonal excitability parameters remain normal in mitochondrial 
disease during and after ischaemia 
 
(Ng et al., 2013)
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Chapter 4F   
Motor axon excitability in multiple sclerosis indicates slow K+ 
channel upregulation  
 
(Ng et al., 2008)
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Chapter 4G  
Sensory nerve excitability in multiple sclerosis indicates altered 
fast K+ channel kinetics  
 
(Ng et al., 2013) 
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Correlation with clinical features, and sensitivity of nerve 
excitability techniques 
Introduction 
It has been some 15 years now that the TROND technique has been available to assess rapidly 
the excitability of peripheral nerves and since then, many conditions have been studied (see 
Table 1.3, Chapter 1). Most pathogenic peripheral nerve conditions studied have revealed clear 
abnormalities with an increase in absolute threshold. However, there are conditions that do 
not have excitability abnormalities, as evidenced by the studies in mitochondrial disease in 
chapters 4D and 4E of this thesis. Most studies to date have been able to demonstrate not only 
significant reproducibility within subjects (Tomlinson et al., 2010), but also significant 
differences in group-to-group comparisons. However, these studies do beg the question of 
how sensitive nerve excitability techniques are, for diagnosing a neuropathy and if there is a 
correlation of its parameters with clinical features of neuropathy in that condition. The studies 
in Chapter 4 of this thesis were designed to provide insights into pathophysiology. The power 
to demonstrate clinical importance was not explored as such, and could well require larger 
cohort sizes. Nevertheless, it can be instructive to examine whether studies of axonal 
excitability add relevant information to clinical features and standard nerve conduction 
techniques. In Part A of this chapter, analyses were performed for end-stage liver disease, HIV 
neuropathy and mitochondrial disease, to contrast the value of excitability testing with that of 
routine NCS. No such analysis was performed for MS because conventional tests of peripheral 
nerve function are of no value in this disorder, and clinical signs do not necessarily localise the 
lesion to the CNS or PNS.  
The analysis of excitability parameters often employs multiple group-to-group comparisons. It 
should be noted that although we will be seeking associations of previously demonstrated 
significant changes with clinical signs and NCS (except in the case of mitochondrial disease – 
see below), this use of multiple comparisons does necessitate a conservative interpretation of 
the findings, especially if the P values reveal only a weak association for these previously 
demonstrated excitability changes in the original report. Part B will look at the number of 
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patients who fall outside the 95% CI, to try to ascertain if the test is useful in detecting an 
individual patient with an abnormality of any parameter.  
Part A   
Correlation with clinical features of peripheral neuropathy 
End-stage liver disease and hepatic neuropathy 
In this group of 11 patients (Table 1 of chapter 4A), there were 6 deemed to have a 
neuropathy on clinical grounds. Three had large, and three had small fibre signs. Sensory 
symptoms were ignored because their presence did not necessarily indicate a neuropathy. 
There were no patients who manifested weakness, but some did report cramp. The nerve 
conduction studies were abnormal in all patients who had evidence of large fibre clinical signs 
and in two others with no objective clinical evidence for a neuropathy. One of these two latter 
patients had symptoms, and this serves to underline the complementary role of nerve 
conduction to the clinical examination in the detection of neuropathy.  
As noted in the final paragraph of the results section of chapter 4A, there was no significant 
correlation with clinical (large or small fibre) signs of the significantly different excitability 
parameters. The changes suggested ischaemia (reduced superexcitability, reduced TEd 90, and 
increased resting I/V slope). Similarly, there was no correlation of these parameters with 
hepatic impairment scores, autonomic neuropathy or modified total neuropathy scores 
(mTNS). A further analysis was undertaken in this section, after the publication of that study: 
to compare patients with either large or small fibre clinical signs in any part including the lower 
limbs (n=6, putative evidence for a neuropathic process: liver disease can cause both large and 
small fibre dysfunction). Comparisons were made using Students t-test of the significantly 
different parameters with the remainder of the cohort, and the results are presented in the 
following tables.  
The order of presentation of the following results respects previous observations of the 
relative sensitivity of the 3 excitability parameters to changes in membrane potential (Kiernan 
and Bostock, 2000). In that study, TEd (90-100ms) had the strongest correlation with the 
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polarising current used to change membrane potential (r = -0.92). In Table 5.1, a significant 
difference was observed only for the peroneal motor TEd (90-100ms) values when comparing 
the groups with and without clinical signs. This is intuitively satisfying as most of the clinical 
signs were detected in the lower limbs. The difference cannot be fully accounted for by age (54 
vs 46 years, non-significant) as one study found less than 1% threshold difference in this 
parameter over a decade (Bae et al., 2008). 
Table 5.1. Association of 
excitability measures with 
clinical signs 
Upper Limb Lower Limb 
Large or 
small 
fibre 
signs 
(n=6) 
No large 
or small 
fibre 
signs 
(n=5) P value 
Large 
and 
small 
fibre 
signs 
(n=6) 
No large 
or small 
fibre 
signs 
(n=5) P value 
Motor TEd (90-100ms) 39.3 42.5 0.27 37.3 42.1 0.03* 
Superexcitability -15.9 -22.3 0.10 -11.2 -15.0 0.33 
Resting I/V slope 0.72 0.73 0.90 0.75 0.65 0.09 
Sensory TEd (90-100ms) 45.5 49.2 0.25 n/a n/a n/a 
Superexcitability -12.97 -13.77 0.83 n/a n/a n/a 
Resting I/V slope 0.68 0.56 0.14 n/a n/a n/a 
For all tables in this chapter: AbN = abnormal, superexcitability expressed as %; threshold electrotonus is 
shown with +/-40% of conditioning current 
The following shows the comparisons between those with (n=4) and without NCS 
abnormalities (n=7) (Table 5.2), and between those who did (n=8) and did not have (n=3) any 
indication of a neuropathy (large or small fibre clinical signs or NCS abnormality) (Table 5.3). 
Table 5.2 shows that NCS did not clearly predict which patients had excitability abnormalities. 
A NCS abnormality was found in 2 of 6 patients with signs and 2 of 5 without signs. 
Table 5.3 looks at the parameters by signs and/or nerve conduction abnormalities. There was 
no meaningful relationship, other than the difference in TEd (90-100ms) consistent with 
depolarisation in the lower limb, as noted in Table 5.1. Again, although the patients were 
older, they were not significantly so (age 54.3 vs 40.7 years for lower limb motor excitability 
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studies). Therefore, again, this difference in age is unlikely to affect the above excitability 
measures to this extent (Bae et al., 2008). 
 
 
Table 5.2. Association between 
excitability and a nerve 
conduction abnormality 
Upper Limb Lower Limb 
NCS abN 
(n=4) 
NCS 
normal 
(n=7) P value 
NCS abN 
(n=4) 
NCS 
normal 
(n=7) P value 
Motor TEd (90-100ms) 43.9 39.0 0.08 39.9 39.2 0.65 
Superexcitability -21.2 -17.5 0.39 -16.0 -11.2 0.23 
Resting I/V slope 0.61 0.79 0.13 0.70 0.70 0.89 
Sensory TEd (90-100ms) 49.5 45.9 0.32 n/a n/a n/a 
Superexcitability -18.8 -10.2 0.02* n/a n/a n/a 
Resting I/V slope 0.53 0.65 0.16 n/a n/a n/a 
 
Table 5.3. Association of 
excitability and any indicator 
for a clinical neuropathy 
(clinical signs or NCS 
abnormality) 
Upper Limb Lower Limb 
NCS or 
signs 
abN 
(n=8) 
NCS and 
signs 
normal 
(n=3) P value 
NCS or 
signs 
abN 
(n=8) 
NCS and 
signs 
normal 
(n=3) P value 
Motor TEd (90-100ms) 40.1 42.5 0.46 37.4 44.0 0.01* 
Superexcitability -17.3 -22.9 0.22 -12.1 -15.2 0.50 
Resting I/V slope 0.71 0.75 0.78 0.72 0.65 0.23 
Sensory TEd (90-100ms) 46.1 50.1 0.27 n/a n/a n/a 
Superexcitability -13.5 -13.0 0.89 n/a n/a n/a 
Resting I/V slope 0.65 0.55 0.30 n/a n/a n/a 
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Comment:  
Changes in excitability were correlated with clinical signs in the legs but not NCS. When 
abnormal signs and NCS were considered together, NCS findings did not add to the diagnostic 
yield. As TEd (90-100ms) is the parameter most sensitive to depolarisation, the association is 
likely to be clinically relevant. Although the sample size was sufficient to demonstrate 
abnormalities of axonal excitability in end-stage liver disease, the present post-hoc analysis 
probably requires a larger sample to make more firm conclusions. 
HIV neuropathy 
The studies in chapter 4C examined 16 patients with HIV infection, of whom 14 had a clinical 
neuropathy either with objective signs or on nerve conduction studies. These patients with 
neuropathy were subdivided into distal sensory polyneuropathy / viral neuropathy (‘VN’, n=10) 
or nucleoside neuropathy (‘NN’, n=4). As there were a large number of patients (n=14) in this 
cohort with a neuropathy (recruitment was primarily aimed at discovering an excitability 
difference in neuropathic patients), a correlation or co-segregation of the excitability findings 
with clinical signs or nerve conduction abnormalities was sought. The 2 patients who had no 
neuropathic features clinically or on NCS were included in the analysis.  
Within the VN group (n=10), there were 8 patients (80%) with physical signs (pinprick sensory 
loss, absent ankle jerks or both, but not tactile sensory loss). Two patients had mild distal 
weakness, and 9 had NCS abnormalities.  Within the NN group, all patients had physical signs 
but none had weakness. Three had nerve conduction abnormalities. Significant excitability 
changes were found only in the NN group. It cannot be concluded that signs or NCS 
abnormalities were more prevalent in the NN group, given the high number with abnormal 
signs or NCS abnormality in both groups. 
In the next exercise, the 16 HIV patients were subdivided into those with and without clinical 
signs, leaving aside the cause of neuropathy. Multiple excitability parameters were examined 
in a group to group analysis with Student’s t-test to look for differences, and the significant 
findings presented in Tables 5.4 and 5.5 below, for median motor and sensory excitability 
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respectively. Comparison with the same age-matched control group is also presented. 
Adequate sensory excitability studies were recordable in only 10 patients. 
Table 5.4. 
Association of 
motor excitability 
with clinical signs 
No 
clinical 
signs 
(n=4) 
P 
value 
Clinical 
signs 
(n=12)  
Clinical 
signs 
NN 
(n=4) P value 
Controls 
(n=40) 
P 
value 
Clinical 
signs 
not NN 
(n=8) 
(Age) 42.8 0.03* 54.5  52.0 0.24 46.8 0.01* 55.8 
TEd (90-100ms) 45.4 0.21 42.3  40.9 0.07 45.3 0.19 43.0 
TEd (40-60ms) 49.5 0.33 47.4  44.4 0.006* 51.8 0.12 48.9 
TEd peak 66.7 0.70 65.4  62.4 0.02* 69.0 0.32 67.0 
Superexcitability -25.2 0.28 -21.52  -18.6 0.07 -24.3 0.58 -23.0 
Resting I/V slope 0.59 0.53 0.66  0.78 0.01* 0.60 0.89 0.60 
 
In this analysis of motor axons, there were no significant differences in excitability parameters 
between the groups with clinical signs and those without. Those without clinical signs had 
values that were comparable to control values for excitability. It can also be seen that the 
significant differences between those with clinical signs and controls were largely due to the 
NN group, with abnormalities that were reported in chapter 4C.  
Table 5.5 shows there were no significant differences in the sensory excitability parameters 
based on the presence of clinical signs. Comparisons with controls revealed an increase in 
latency in those with clinical signs, despite the patient cohort being significantly warmer. The 
decreased RRP and lesser refractoriness in the patients are probably due, at least in part, to 
the higher temperatures in the patients.  
Only 2 patients did not have NCS abnormalities. When the 14 patients with nerve conduction 
abnormalities were compared with the 40 age-matched controls with respect to median motor 
excitability, there were changes only in the peak response (5.4 vs 7.9 mV, P=0.005), 
temperature (33.7 vs 32.7 degrees 
o
C, P=0.005), latency (7.2 vs 6.6 ms, P=0.03), TEd 40-60 
(48.3 vs 51.8%, P=0.02), and refractoriness at 2 ms (61.5 vs 81.1%, P=0.04).  
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Table 5.5. Association of 
sensory excitability with 
clinical signs 
No clinical 
signs (n=3) P value 
Clinical signs 
(n=7) P value 
Controls 
(n=17) 
Age 44.7 0.60 48.2 0.90 44.1 
SR slope 2.2 0.43 2.0 0.02* 2.6 
Temperature 34.9 0.82 35.1 0.003* 33.7 
Latency of response 3.9 0.92 3.9 0.002* 3.5 
RRP 3.1 0.41 2.9 0.005* 3.6 
Refractoriness 2.5ms 13.7 0.55 10.6 0.002* 28.8 
Refractoriness 2ms 41.6 0.19 27.6 0.002* 55.3 
Hyperpolarising I/V slope n/a n/a 0.43 0.02* 0.36 
 
Comment:  
Excitability parameters do not appear to correlate with the presence of clinical signs in patients 
with HIV, in that there were no significant differences between those with and without signs. 
The significant excitability changes in the motor studies of patients with clinical signs when 
compared to controls can be explained by a co-segregation of NN patients to the group with 
clinical signs. 
Mitochondrial neuropathy 
As noted in Chapter 4D, there were no changes in motor nerve excitability in the original 
cohort of 16 individuals who had mitochondrial disease (of whom 8 had MELAS). The 
subsequent study in Chapter 4E was undertaken to determine the changes in excitability 
during and after ischaemic stress in 13 patients, all of whom had MELAS. As a group, there 
were no significant motor differences between 27 undifferentiated patients with 
mitochondrial disease (2 patients from the first study [chapter 4D] were restudied in the 
second study [chapter 4E]) and controls, and this was the same for the MELAS subset (n=19). 
Similar negative findings were noted in the combined cohort sensory studies and its subset of 
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MELAS patients. Therefore, the combined cohort confirms the original findings in chapter 4D 
that there are no clear changes in excitability in mitochondrial disorders, and specifically in 
MELAS. 
The pooled patient group of 27 were divided into those with clinical signs (not symptoms) of a 
neuropathy (n=16) vs those without neuropathy (n=11). Comparisons between these 2 groups 
and the former with controls are set out in Table 5.6 below for the parameters that were 
different at the 5% level i.e., P<0.05.   
Table 5.6. 
Association of 
excitability with 
clinical signs 
No clinical 
signs (n=11) P value 
Clinical signs 
(n=16) P value 
Controls 
(n=27) 
Motor      
Age 52.5 0.53 48.7 0.30 48.4 
Temperature 34.6 0.76 34.3 0.01* 33.1 
Subexcitability 17.1 0.02* 13.5 0.84 13.8 
Accommodation 
half-time (ms) 
37.5 0.03* 41.6 0.30 40.1 
Sensory      
Age 53.3 0.42 48.5 0.01* 36.8 
Temperature (
o
C) 34.1 0.33 33.4 0.66 33.6 
RRP (ms) 3.0 0.02* 3.6 0.94 3.6 
TEd undershoot -20.8 0.04* -17.3 0.02* -20.5 
Subexcitability, TEd undershoot expressed as % 
Unlike end-stage liver disease and HIV neuropathy, there were no significant excitability 
changes in mitochondrial disease as noted in chapter 4D, to guide this analysis. The 
parameters shown in Table 5.6 represent “significant” differences between either patients 
with and without clinical signs, or between patients with clinical signs and controls. 
Paradoxically, although this post-hoc analysis revealed differences between patients with and 
without clinical signs for some parameters, the properties of the patients with clinical signs 
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were similar to control values, except for one measure (TEd undershoot). However, the 
different parameters were not the same for motor and sensory axons, and the relevance of the 
findings can be questioned, given the multiple comparisons.  
Table 5.7. Association of excitability 
with a NCS abnormality 
 
NCS normal 
(n=21) P value 
NCS 
abnormal 
(n=6) P value Controls 
Motor     (n=27) 
Age 48.0 0.15 57.8 0.10 48.4 
TEd (10-20ms) 69.2 0.03* 64.4 0.03* 70.1 
TEd peak 68.7 0.03* 63.7 0.02* 69.5 
Sensory     (n=17) 
Age 48.3 0.17 57.8 0.007* 44.1 
Temperature 34.5 0.56 35.2 0.06 33.7 
RRP (ms) 3.0 0.02* 3.6 0.92 3.6 
TEd undershoot -19.6 0.03* -15.13 0.02* -20.3 
 
A similar analysis was performed in Table 5.7 for NCS abnormalities (n=6). This is a small 
number because the original design of the study was not necessarily of patients with a clinical 
neuropathy. Here, there was  a difference between motor axons of patients with and without 
NCS abnormalities, with values for the latter group approaching those of controls (with the 
exception of RRP in sensory axons). There is an apparent reduction of threshold change to 
depolarising conditioning current in motor axons, but the pathophysiological implications are 
uncertain. 
Comment: 
The above analyses imply that the presence of NCS abnormalities may be correlated with 
excitability abnormalities (Table 5.7). However, clinical signs are not predictive of excitability 
abnormalities (Table 5.6). This can be explained by the fact that signs may result from a lesion 
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anywhere in the neuraxis, not just peripheral nerve, particularly in mitochondrial disorders 
where CNS involvement is common. 
Part B  
Sensitivity of nerve excitability methods to distinguish abnormal 
individuals 
In previous studies of cohorts of patients with different neurological disorders, the findings for 
individual subject’s results were commonly within control 95% confidence limits, though this 
was not so in some studies of the central channelopathies, for example, episodic ataxia and 
benign neonatal familial convulsions (Tomlinson et al., 2010, Tomlinson et al., 2012) and some 
acquired peripheral disorders such as uraemic and diabetic neuropathy (Kiernan et al., 2002, 
Krishnan and Kiernan, 2005). Therefore, excitability techniques hold some promise of not only 
illuminating pathophysiology, but also assisting in the diagnosis of these disorders. This section 
addresses whether this holds true in the cohorts that make up this thesis.  
End-stage liver disease 
The original findings in TEd (90-100ms), resting IV slope and superexcitability of median and 
peroneal motor nerves were replotted below with superimposed individual traces on 95%CI 
limits for controls that were used in the original publication.  
Findings: 
Figure 5.1 shows that the following individual subject(s) had measures outside 95%CI for 
controls: none for a reduction in median motor TEd (90-100ms) (A), two for a reduction in 
median motor superexcitability (B), and two for a reduction in peroneal motor superexcitability 
(C). Figures B and C ‘outliers’ were the same 2 patients, with one of these 2 also having an 
outlier with an increased resting I/V slope (not shown). This may indicate a concordance in that 
one patient who is perhaps more severely affected by neuropathy. Overall, the data for 2 (18%)  
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of 11 individuals were outside these confidence intervals.   
 
Figure 5.1. (A) Median motor threshold electrotonus; (B) Median motor recovery cycle; (C) 
Peroneal motor recovery cycle 
A        B             C 
-200
-100
0
100
Th
re
sh
o
ld
 
re
du
ct
io
n
(%
)
0 100 200
Delay (ms)
Th
re
sh
o
ld
 
re
du
ct
io
n
(%
)
0
100
Th
re
sh
o
ld
 
ch
a
n
ge
(%
)
10 100
Interstimulus interval (ms)
Th
re
sh
o
ld
 
ch
a
n
ge
(%
)
0
100
Th
re
sh
o
ld
 
ch
a
n
ge
(%
)
10 100
Interstimulus interval (ms)
Th
re
sh
o
ld
 
ch
a
n
ge
(%
)
 
Legend for Figures 5.1-5.3: The red dashed line represents the 95%CI for control subjects, and the outlier 
points are highlighted in blue. Threshold electrotonus is shown with +/-40% conditioning current. 
 
 
HIV infection 
The original findings in Chapter 4C of resting IV slope, TEh (90-100ms), TEd (40-60ms), TEd 
peak and superexcitability at 7 ms of median motor nerves of patients with NN are replotted 
below in Fig 5.2 with superimposed individual traces on 95%CI limits for controls that were 
used in the original publication.  
Findings: 
There was one outlier that had both reduced TEd (40-60 ms) and TEd peak in Fig. 5.2A. There 
were no outliers in the recovery cycle (Fig 5.2B). Therefore, one (25%) of 4 NN patients in this 
group was outside control 95%CI.  
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Figure 5.2. (A) Median motor threshold electrotonus; (B) Median motor recovery cycle 
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Mitochondrial disease 
In Chapter 4D, there were 6 individuals who had NCS abnormalities in a cohort of 27 
mitochondrial disease patients who may not necessarily have manifested clinical signs of 
neuropathy. These same individuals are plotted against 27 of the original controls in that study 
for median motor TEd (10-20ms) and TEd peak, and median sensory TEd undershoot (see Fig. 
5.3). These were the only parameters found to be significantly different in this group when 
comparing patients with NCS abnormality to controls (see Table 5.7).  
Figure 5.3. (A) Median motor threshold electrotonus; (B) Median sensory threshold 
electrotonus 
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Findings:  
There was only one outlier (A) who had reduced median motor TEd peak and two outliers with 
reduced median sensory depolarising undershoot (B), with one patient common to both. 
Therefore, there were 2 (33%) of 6 patients in this disease cohort who fell outside the 95%CI for 
individual parameters.  
Conclusions to Part A and B 
In end-stage liver disease, abnormalities of excitability in the lower limb appear to be 
associated with lower limb clinical signs. This association may be explained by a length-
dependence of this neuropathy, which is clinically evident in that condition. There was no 
association with NCS abnormalities. However, in mitochondrial disease, the reverse was true 
with excitability abnormalities only associated with NCS abnormalities and not clinical signs. 
This may be due to the fact that signs may arise from the central neuraxis, and those regions 
are not as easily probed by NCS or excitability techniques. Excitability changes in HIV 
neuropathy could only be demonstrated in the NN group, and did not appear to be related to 
clinical signs or NCS abnormalities.  
It can be concluded that the technique may not be particularly sensitive as a diagnostic test in 
these disorders and is commonly not concordant with conventional indicators of a neuropathy 
(clinical signs or NCS). However, numbers were small in these analyses. Nevertheless, since the 
studies in this thesis were conducted, some peripheral neuropathic conditions with marked 
neuropathy have been observed to lack changes in excitability, even when there are marked 
abnormalities in physical examination and NCS. This is seen for example in personal as-yet 
incomplete studies conducted by the author of cohorts with amyloid neuropathy and past-
polio neuropathy. This can be explained by the fact that these domains test different things: (i) 
NCS test speed and the ability of axons to conduct; (ii) signs occur only when there are too few 
conducting axons; (iii) symptoms occur when there are too few conducting axons and/or axons 
discharge ectopically (e.g. paraesthesiae, pain, fasciculation, etc); (iv) excitability studies test 
axons at the site of stimulation only. 
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The relative sensitivity of the technique to show an abnormality in an individual that is 
concordant with the group difference from controls, remains at 18% and 25% for end-stage 
liver disease and NN respectively when employing 95% CI limits for controls. In mitochondrial 
disease, where excitability differences were noted in the comparison of the abnormal NCS 
group to controls, only 33% of these individuals had any of these same excitability 
abnormalities that were outside 95% CI limits for controls. 
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Summary and conclusions 
The studies in this thesis have investigated the pathophysiology of peripheral neuropathy in 
three conditions using peripheral nerve excitability techniques. From these findings, analyses 
were undertaken to establish if the nerve excitability changes were correlated with 
conventional clinical and neurophysiological measures for a peripheral neuropathy. In this 
fashion, an attempt was made to establish if studying nerve excitability could be more 
sensitive in detecting neuropathy (on the basis that more severe disease would result in a 
more severe neuropathy) or if it was complementary to the existing methods. Any study of 
excitability techniques needs to take into account changes in peripheral nerve excitability that 
may arise from disorders of the central neuraxis, and this effect was explored in both the 
motor and sensory nerves of patients with multiple sclerosis, noting that there is some 
historical literature on the existence of peripheral nerve involvement in MS. 
In Chapter 4A, the pathophysiology of neuropathy in end-stage liver disease was studied. This 
is generally a mild process. In 11 patients, it was established that the most sensitive measure 
for detecting neuropathy was thermal threshold estimation, and with a pattern of greater 
warm than cold perception involvement. This was seen in 10 of the 11 patients who were not 
selected for the presence of a neuropathy. Clinical findings were the next most prevalent, 
followed by large fibre conduction and autonomic study abnormalities. The group 
demonstrated changes in nerve excitability in comparison to controls, and these changes were 
suggestive of chronic nerve ischaemia. The degree of axonal depolarisation appeared to be 
small, possibly due to ischaemia secondary to either nitric oxide-endothelin imbalances that 
render endoneurial ischaemia, perhaps compounded by loss of intravascular volume. An effect 
of a neurotoxin that caused these changes by paralysis of the Na
+
-K
+
 pump could not be 
excluded. There were no correlations of these excitability parameters to hepatic impairment 
scores, the modified TNS, or with the presence of clinical large or small fibre signs. One 
limitation of the excitability studies in this experiment is that these studies are limited to large 
fibres which appear to be less affected. Another limitation of this study was the inability to 
exclude an effect of alcoholic polyneuropathy, a possible confounder in some subjects. 
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However, aside from refractory period changes, there were no exceptional changes in that 
subgroup.  
In Chapter 4B, 6 patients from the group in Chapter 4A underwent liver transplantation, and 
were followed after one year. The changes in excitability suggestive of ischaemia in the 
previous study did not reverse, but there was a trend noted towards control values in the 
three most sensitive parameters. Therefore, it would appear that the changes do not clearly 
indicate a reversible process from ischaemia or a neurotoxin. A limitation of this study is the 
short period before the follow-up study. In that short period, sural conduction velocities 
appeared to normalise significantly, and it is possible that the excitability changes would have 
done so given a sufficiently long period. There was a normalisation of autonomic dysfunction 
in one patient, but no clear change for better or worse in thermal detection (unpublished 
observations). 
In Chapter 4C, 16 patients with HIV infection were studied, 14 of whom had peripheral 
neuropathy. Excitability changes could only be demonstrated in the 4 patients with nucleoside 
neuropathy, but not in the 10 patients with viral distal polyneuropathy. The changes were 
consistent with axonal depolarisation, possibly due to mitochondrial dysfunction via graded 
inhibition of γ-DNA polymerase. This mechanism has been implicated in the effect of 
antiretroviral agents (in this case, d4T in three, and ddC in one). This is likely to be a more 
diffuse process than that suspected in distal viral polyneuropathy which is characterised by 
upregulated Na
+
 channels and hyperexcitability at the dorsal root ganglion. This study 
therefore suggested a method to distinguish these two common forms of neuropathy in the 
setting of HIV infection, something that is difficult presently on clinical and laboratory grounds. 
Limitations of this study include the inability to study the effect of HIV infection alone in the 
absence of neuropathy, because there were only two such patients in this cohort.  
In Chapter 4D, 16 individuals with either genetic or muscle biopsy evidence for mitochondrial 
disease were studied to test an a priori assumption that their peripheral nerves would appear 
depolarised because of a lack of substrate for energy-dependent processes such as the Na
+
-
K
+
ATPase pump via mitochondrial dysfunction. No changes were seen of such and the 
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membrane potential appeared unaltered. Possible explanations for this negative finding 
include heteroplasmy (although changes were not noted in those with neuropathy), and that 
mitochondrial neuropathy may actually represent a Schwannopathy. There were a large 
number of patients with impaired glucose tolerance in this study as befits its prevalence in this 
condition but, although these patients were more likely to be neuropathic, no changes were 
observed in that subgroup. This is despite previously published excitability changes in diabetic 
neuropathy. A limitation of the study was the low number of patients with definite 
neuropathy, as indicated by standard nerve conduction techniques in that cohort (n=5). 
Clinical signs can also be less reliable in this condition given the high prevalence of central 
neuraxis affliction. A concurrent myopathy was not pronounced and not likely to interfere with 
the excitability findings. 
In Chapter 4E, because of the lack of changes in noted in chapter 4D, thirteen individuals with 
MELAS syndrome secondary to A3243G mutation were studied in an ischaemic experiment. 
This study validated the previous negative findings for the resting threshold study in Chapter 
4D in this group as well as the larger combined cohort. This 10-min period of cuff inflation 
failed to find any differences in behaviour compared to healthy controls. This was relevant 
even for those few patients with glucose intolerance. The findings suggest that outside of a 
crisis, there are no gross abnormalities in axonal excitability in this disorder, and it raises the 
possibility that any static peripheral deficit is the result of cumulative damage which only 
poorly correlates with nerve excitability measures (see later). 
In Chapter 5A, correlations were drawn between excitability changes seen in the end-stage 
liver disease neuropathy and HIV neuropathy, to determine if there was a link between 
excitability abnormalities and the presence of clinical signs or conventional nerve conduction 
abnormalities. Nerve excitability parameters that were significantly different in end-stage liver 
disease correlated with the presence of large fibre signs in the legs, but nerve conduction 
studies did not add anything further. In contrast, in mitochondrial disease, some excitability 
parameters appear to correlate with nerve conduction abnormalities, but not clinical signs, 
which is intuitive as signs may be derived from central deficits. Any changes noted in 
excitability in HIV neuropathy can be explained solely by nucleoside neuropathy, and was not 
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readily correlated with clinical signs. Common limitations of these analyses were the small 
numbers of patients, so some caution is advised with these interpretations.   
In Chapter 5B, approximately 1 in 5 (18%) patients with end-stage liver disease and nucleoside 
neuropathy had excitability parameters that were outside 95% CI control limits. This is smaller 
than with abnormalities detected on clinical signs (55%) and nerve conduction (36%) grounds 
in end-stage liver neuropathy, and on clinical signs (75%) and nerve conduction (100%) 
grounds in nucleoside neuropathy. Therefore, it would appear that excitability techniques are 
not particularly sensitive in these two cohorts for demonstrating an abnormality in an 
individual, and will likely remain at most complementary to existing methods of clinical 
examination and nerve conduction with regards to sensitivity.  
In conclusion, nerve excitability cannot be assumed to correlate with clinical signs in peripheral 
neuropathic conditions and, in fact, failed to demonstrate abnormalities in comparison to 
healthy controls subjects in some diseases where there were clear clinical signs or nerve 
conduction abnormalities. This emphasises that the technique is complementary to diagnostic 
skills and presently available techniques in the investigation of the peripheral nervous system.  
In Chapter 4F, 12 patients with stable MS were studied to analyse the effect of central lesions 
on the excitability of peripheral motor neurons. An increase of slow K
+
 channel conductance 
via upregulation of KCNQ2/3 was suggested by various excitability parameters, and the effects 
were modelled by an 11% increase in the conductance of that ion channel. There was however 
no correlation of this parameter with MS subtypes, disease duration or activity, and disability 
scales. Central disconnection has been previously shown to lead to changes in peripheral 
nerves. The MS patients had multiple lesions both in the brain and spinal cord, and these 
appeared distinct from other central disorders such as stroke and subacute/chronic spinal cord 
injury. These unique changes in MS may therefore represent disruption of spinal cord circuitry 
and the resultant alterations in motor neuronal excitability at the cell soma/ axon hillock, 
which occur chronically rather than acutely with spinal cord injury. The other possibility is that 
there may be interruption of suprasegmental influences that may be bilateral in MS, in 
contrast with the mostly unilateral interruption in hemispheric stroke. One limitation of this 
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study was the inability of MR imaging to definitively document motor (and sensory) pathway 
involvement. Normal appearing white matter may harbour many physiological deficits. 
Further, lesions are likely to be patchy and multifocal within the central neuraxis in MS. 
Therefore, it can be difficult to definitively tie any changes in motor excitability to a particular 
deficit in the motor (or sensory) unit. Nevertheless, the prevalence of multiple cord lesions in 
this disorder would appear to distinguish the findings in this disorder from those seen in other 
similar central disorders.  
In chapter 4G, a larger MS cohort was recruited to assess possible peripheral sensory 
excitability changes. Firstly, motor findings seen in chapter 7 were reproduced and validated in 
26 patients (which included 12 patients from the original cohort). Sensory studies on 22 
patients manifested reduced superexcitability in the recovery cycle. This is mostly consistent 
with the historical literature assessing this parameter on sensory nerves in MS. The modelling 
did not suggest less myelin lamellae via a reduction in capacitance, or paranodal demyelination 
via a simple increase in fast K
+
 channel conductance, because these would have produced 
changes in other excitability measures. However, when the voltages for half-activation were 
altered in modelling experiments, an increase in fast K
+
 kinetics was sufficient to reproduce the 
findings seen in this study. Therefore, unlike motor axons, the findings in peripheral sensory 
nerves in our MS cohort appear to be due to local effects at the peripheral nerve, possibly by 
loosening of the paranodal seal allowing greater access by immune factors to fast K
+
 channels 
to that region. This is indeed tantalising, indicating some immune ‘spill-over’ of the 
immunological process outside the central nervous system in MS, possibly to affect common 
epitopes within the peripheral nervous system at the juxta-paranodal region. 
Perspectives for future work 
The studies here have provided some pathophysiological insights into selected peripheral 
neuropathic disorders. Two of our cohorts manifested changes that were consistent with 
depolarisation, presumed to be secondary to an ischaemic phenomenon. In this regard, there 
are some potentially important future studies. Although we demonstrated no inherent 
differences in axonal excitability in mitochondrial disorders, the Na
+
-K
+ 
ATPase pump could be 
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further taxed in this disorder with experiments that employ maximal voluntary contraction. 
Furthermore, to validate many historical interpretations of experiments manifesting 
membrane depolarisation as being indicative of ischaemia, the effects of true chronic 
ischaemia should be studied in a cohort with chronic peripheral vascular disease. This type of 
situation would more accurately resemble a potentially chronic ischaemic state if this is an 
important mechanism in some peripheral neuropathies, and would be influenced by the 
effects of obligatory compensatory changes in excitability in response to ongoing ischaemia 
that occur over time. Only one account of a case exists in the literature of vascular 
insufficiency (Huynh et al., 2011).  However, there was insufficient information in that report 
to conclude if the patient was suffering from acute or chronic ischaemia. 
Although these studies indicate only limited diagnostic value of the excitability techniques in 
distinguishing individual subjects with a disorder, this may not be the case in the genetic 
channelopathies. Larger cohorts may be required to detect correlations of excitability 
parameters to neuropathy severity in future studies, but it is evident that some forms of 
peripheral neuropathy will not demonstrate marked changes in the excitability, except for 
expected changes in rheobase. There would appear to be value of the technique in monitoring 
disease, such as has been employed to date for example, in chemotherapy-induced, diabetic 
neuropathy and ALS , as well as to follow the treatment of CIDP and uraemic neuropathy (Park 
et al., 2009, Cheah et al., 2012, Sung et al., 2012, Arnold et al., 2013). 
The effects of CNS lesions on peripheral motor axons appear disparate in the literature, and 
the studies in this thesis raise the question of whether the findings demonstrated in MS are 
specific to that disease, or specific to the topography of the lesion and/or pattern of its 
development. If the assertion is that these changes are unique because of the presence of 
multiple or diffuse spinal cord pathology, then future studies could explore this further in 
patients with MS who have either exclusively spinal or exclusively brain lesions. The role of 
bilateral descending interruption which is assumed in spinal cord lesions can be probed with 
the study of bilateral hemispheric strokes. Understanding may also be enhanced by studies of 
slowly-evolving non-demyelinating lesions of the spinal cord to prove/disprove the assertion 
that the changes in this study were not similar to spinal cord injury because of the rapidity of 
the insult.
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